<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:25:41Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9751849" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9751849</identifier>
        <datestamp>2022-12-15</datestamp>
        <setSpec>nihpa</setSpec>
        <setSpec>pmc-open</setSpec>
        <setSpec>manuscript</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
              <journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
              <journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
              <journal-id journal-id-type="iso-abbrev">Neurobiol Dis</journal-id>
              <journal-title-group>
                <journal-title>Neurobiology of disease</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0969-9961</issn>
              <issn pub-type="epub">1095-953X</issn>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9751849</article-id>
              <article-id pub-id-type="pmcid">PMC9751849</article-id>
              <article-id pub-id-type="pmc-uid">9751849</article-id>
              <article-id pub-id-type="pmid">35550158</article-id>
              <article-id pub-id-type="pmid">35550158</article-id>
              <article-id pub-id-type="doi">10.1016/j.nbd.2022.105748</article-id>
              <article-id pub-id-type="manuscript">nihpa1856912</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Association between lower body temperature and increased tau pathology in cognitively normal older adults</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Blessing</surname>
                    <given-names>Esther M.</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                  <xref rid="CR1" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Parekh</surname>
                    <given-names>Ankit</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Betensky</surname>
                    <given-names>Rebecca A.</given-names>
                  </name>
                  <xref rid="A3" ref-type="aff">c</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Babb</surname>
                    <given-names>James</given-names>
                  </name>
                  <xref rid="A4" ref-type="aff">d</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Saba</surname>
                    <given-names>Natalie</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Debure</surname>
                    <given-names>Ludovic</given-names>
                  </name>
                  <xref rid="A4" ref-type="aff">d</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Varga</surname>
                    <given-names>Andrew W.</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ayappa</surname>
                    <given-names>Indu</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rapoport</surname>
                    <given-names>David M.</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Butler</surname>
                    <given-names>Tracy A.</given-names>
                  </name>
                  <xref rid="A5" ref-type="aff">e</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>de Leon</surname>
                    <given-names>Mony J.</given-names>
                  </name>
                  <xref rid="A5" ref-type="aff">e</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wisniewski</surname>
                    <given-names>Thomas</given-names>
                  </name>
                  <xref rid="A4" ref-type="aff">d</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lopresti</surname>
                    <given-names>Brian J.</given-names>
                  </name>
                  <xref rid="A6" ref-type="aff">f</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Osorio</surname>
                    <given-names>Ricardo S.</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                  <xref rid="A4" ref-type="aff">d</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>a</label>Department of Psychiatry, NYU Grossman School of Medicine, New York, NY 10016, United States of America</aff>
              <aff id="A2"><label>b</label>Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States of America</aff>
              <aff id="A3"><label>c</label>Department of NYU School of Global Public Health, New York, NY 10016, United States of America</aff>
              <aff id="A4"><label>d</label>Alzheimer’s Disease Research Center, Department of Neurology, NYU Grossman School of Medicine, New York, NY 10016, United States of America</aff>
              <aff id="A5"><label>e</label>Department of Neurology, Weill Cornell Medicine, New York, NY 10065, United States of America</aff>
              <aff id="A6"><label>f</label>Department of Radiology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America</aff>
              <author-notes>
                <corresp id="CR1"><label>*</label>Corresponding author: <email>esther.blessing@nyulangone.org</email> (E.M. Blessing).</corresp>
              </author-notes>
              <pub-date pub-type="nihms-submitted">
                <day>10</day>
                <month>12</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>9</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>10</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>15</day>
                <month>12</month>
                <year>2022</year>
              </pub-date>
              <volume>171</volume>
              <fpage>105748</fpage>
              <lpage>105748</lpage>
              <permissions>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the CC BY-NC-ND license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract id="ABS1">
                <sec id="S1">
                  <title>Background:</title>
                  <p id="P1">Preclinical studies suggest body temperature (Tb) and consequently brain temperature has the potential to bidirectionally interact with tau pathology in Alzheimer’s Disease (AD). Tau phosphorylation is substantially increased by a small (&lt;1 °C) decrease in temperature within the human physiological range, and thermoregulatory nuclei are affected by tau pathology early in the AD continuum. In this study we evaluated whether Tb (as a proxy for brain temperature) is cross-sectionally associated with clinically utilized markers of tau pathology in cognitively normal older adults.</p>
                </sec>
                <sec id="S2">
                  <title>Methods:</title>
                  <p id="P2">Tb was continuously measured with ingestible telemetry sensors for 48 h. This period included two nights of nocturnal polysomnography to delineate whether Tb during waking vs sleep is differentially associated with tau pathology. Tau phosphorylation was assessed with plasma and cerebrospinal fluid (CSF) tau phosphorylated at threonine 181 (P-tau), sampled the day following Tb measurement. In addition, neurofibrillary tangle (NFT) burden in early Braak stage regions was imaged with PET-MR using the [18F]MK-6240 radiotracer on average one month later.</p>
                </sec>
                <sec id="S3">
                  <title>Results:</title>
                  <p id="P3">Lower Tb was associated with increased NFT burden, as well as increased plasma and CSF P-tau levels (<italic toggle="yes">p</italic> &lt; 0.05). NFT burden was associated with lower Tb during waking (p &lt; 0.05) but not during sleep intervals. Plasma and CSF P-tau levels were highly correlated with each other (p &lt; 0.05), and both variables were correlated with tau tangle radiotracer uptake (p &lt; 0.05).</p>
                </sec>
                <sec id="S4">
                  <title>Conclusions:</title>
                  <p id="P4">These results, the first available for human, suggest that lower Tb in older adults may be associated with increased tau pathology. Our findings add to the substantial preclinical literature associating lower body and brain temperature with tau hyperphosphorylation. Clinical trial number: <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT03053908" ext-link-type="uri">NCT03053908</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>Tau</kwd>
                <kwd>Phosphorylation</kwd>
                <kwd>Body temperature</kwd>
                <kwd>Aging</kwd>
                <kwd>Alzheimer’s disease</kwd>
                <kwd>Neurofibrillary tangle</kwd>
                <kwd>[<sup>18</sup>F]MK-6240</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="S5">
              <label>1.</label>
              <title>Background</title>
              <p id="P5">Neurofibrillary tangles (NFTs), comprised of hyperphosphorylated aggregated tau protein, are the pathological hallmark of neurodegenerative tauopathies including Alzheimer’s Disease (AD) (<xref rid="R34" ref-type="bibr">Grundke-Iqbal et al., 1986</xref>; <xref rid="R89" ref-type="bibr">Scheltens et al., 2021</xref>). The presence of NFTs, as evidenced by in vivo tau PET imaging, predicts both grey matter volume loss and clinical progression in AD, suggesting NFTs or their soluble tau oligomer precursors promote neurodegeneration (<xref rid="R70" ref-type="bibr">Ossenkoppele et al., 2016</xref>; <xref rid="R73" ref-type="bibr">Pascoal et al., 2017</xref>; <xref rid="R19" ref-type="bibr">Clark et al., 2021</xref>; <xref rid="R71" ref-type="bibr">Ossenkoppele et al., 2021</xref>). Tau is a natively soluble protein that binds to microtubules to stabilize the cytoskeleton and facilitate intracellular trafficking (<xref rid="R37" ref-type="bibr">Guo et al., 2017</xref>; <xref rid="R22" ref-type="bibr">Dixit et al., 2008</xref>; <xref rid="R112" ref-type="bibr">Vershinin et al., 2007</xref>), and may also regulate synaptic plasticity (<xref rid="R58" ref-type="bibr">Kimura et al., 2014</xref>; <xref rid="R10" ref-type="bibr">Biundo et al., 2018</xref>). Tau’s function is modulated by alternative RNA splicing, and by post-translational enzymatic modifications including phosphorylation at over 40 serine and threonine phosphorylation sites (<xref rid="R30" ref-type="bibr">Gong et al., 2005</xref>; <xref rid="R31" ref-type="bibr">Gotz et al., 2019</xref>). Tau hyperphosphorylation is likely to be pathological, given it is observed in soluble precursors of NFTs, and also promotes tau’s detachment from microtubules and subsequent aggregation (<xref rid="R29" ref-type="bibr">Gong and Iqbal, 2008</xref>; <xref rid="R63" ref-type="bibr">Lindwall and Cole, 1984</xref>; <xref rid="R7" ref-type="bibr">Augustinack et al., 2002</xref>; <xref rid="R115" ref-type="bibr">Wegmann et al., 2021</xref>). Mechanisms driving tau hyperphosphorylation are not well understood. Increasing age (<xref rid="R12" ref-type="bibr">Braak and Braak, 1997</xref>), apolipo-protein E (<italic toggle="yes">APOE</italic> genotypes) (<xref rid="R19" ref-type="bibr">Clark et al., 2021</xref>), amyloid beta deposition (<xref rid="R108" ref-type="bibr">van der Kant et al., 2020</xref>; <xref rid="R50" ref-type="bibr">Janelidze et al., 2020</xref>), and cerebrovascular disease (<xref rid="R61" ref-type="bibr">Laing et al., 2020</xref>) have been implicated at the patient level, and imbalances in the activity of tau kinases (<xref rid="R91" ref-type="bibr">Shukla et al., 2012</xref>) and phosphatases (<xref rid="R95" ref-type="bibr">Sontag and Sontag, 2014</xref>), at the molecular level.</p>
              <p id="P6">Temperature, a function of the average speed at which molecules undergo Brownian motion, potently influences tau phosphorylation. Laboratory animal and in vitro experiments over the last 20 years show that a small (&lt; 1 °C) decrease in temperature within the human physiological range substantially increases neuronal tau phosphorylation at sites that are hyperphosphorylated in AD patients (<xref rid="R77" ref-type="bibr">Planel et al., 2004</xref>; <xref rid="R78" ref-type="bibr">Planel et al., 2007</xref>; <xref rid="R32" ref-type="bibr">Gratuze et al., 2017</xref>; <xref rid="R102" ref-type="bibr">Tournissac et al., 2017</xref>; <xref rid="R44" ref-type="bibr">Hitrec et al., 2021</xref>; <xref rid="R64" ref-type="bibr">Luppi et al., 2019</xref>). In vivo, tau phosphorylation is increased by body temperature (Tb) and consequent brain temperature decreases accompanying hibernation (<xref rid="R2" ref-type="bibr">Arendt et al., 1995</xref>; <xref rid="R97" ref-type="bibr">Stieler et al., 2011</xref>), sleep (<xref rid="R35" ref-type="bibr">Guisle et al., 2020</xref>), and hypoglycemia (<xref rid="R77" ref-type="bibr">Planel et al., 2004</xref>). These effects are prevented by maintaining Tb with heating. Regarding mechanism, decreasing Tb inhibits the activity of the major tau phosphatase (PP2A) more so than tau kinase activity, resulting in a net phosphorylation increase (<xref rid="R77" ref-type="bibr">Planel et al., 2004</xref>; <xref rid="R76" ref-type="bibr">Planel et al., 2001</xref>). Importantly, decreasing temperature by &lt;1 °C robustly increases phosphorylation at AD relevant sites on human neuronal tau in vitro (<xref rid="R35" ref-type="bibr">Guisle et al., 2020</xref>; <xref rid="R14" ref-type="bibr">Bretteville et al., 2012</xref>), suggesting that lower human Tb and brain temperature could increase tau phosphorylation and potentially, tau pathology.</p>
              <p id="P7">Whether lower Tb is associated with tau pathology in human has not yet been reported. In wild-type laboratory animals, tau phosphorylation associated with hypothermia is usually reversible upon return to euthermia (<xref rid="R64" ref-type="bibr">Luppi et al., 2019</xref>; <xref rid="R2" ref-type="bibr">Arendt et al., 1995</xref>). However, this reversibility may be impaired in the setting of persistent hypothermia, e.g. that associated with aging (<xref rid="R117" ref-type="bibr">Weitzman et al., 1982</xref>; <xref rid="R56" ref-type="bibr">Kenney and Munce, 2003</xref>; <xref rid="R11" ref-type="bibr">Blatteis, 2012</xref>; <xref rid="R28" ref-type="bibr">Gomolin et al., 2005</xref>), or by molecular alterations associated with age or AD, as previously suggested (<xref rid="R102" ref-type="bibr">Tournissac et al., 2017</xref>; <xref rid="R97" ref-type="bibr">Stieler et al., 2011</xref>; <xref rid="R4" ref-type="bibr">Arendt et al., 2015</xref>) and demonstrated in a mouse model of tauopathy (<xref rid="R80" ref-type="bibr">Planel et al., 2009</xref>). Therefore, lower Tb or disturbed Tb circadian rhythm may be a mechanism whereby age and age-related conditions increase the risk of AD. Further, mitigating thermoregulatory impairment in older adults with targeted Tb interventions could prevent NFT formation (<xref rid="R103" ref-type="bibr">Tournissac et al., 2019</xref>). Finally, relevant to understanding disease progression, a bidirectional relationship may exist between thermoregulatory dysfunction and AD pathology (<xref rid="R102" ref-type="bibr">Tournissac et al., 2017</xref>; <xref rid="R110" ref-type="bibr">Vandal et al., 2016</xref>). Body temperature alterations have been reported in late-stage AD (<xref rid="R65" ref-type="bibr">Mishima et al., 1997</xref>; <xref rid="R41" ref-type="bibr">Harper et al., 2005</xref>; <xref rid="R82" ref-type="bibr">Prinz et al., 1984</xref>; <xref rid="R113" ref-type="bibr">Volicer et al., 2012</xref>; <xref rid="R42" ref-type="bibr">Harper et al., 2008</xref>; <xref rid="R88" ref-type="bibr">Satlin et al., 1995</xref>; <xref rid="R101" ref-type="bibr">Touitou et al., 1986</xref>; <xref rid="R69" ref-type="bibr">Okawa et al., 1991</xref>; <xref rid="R40" ref-type="bibr">Harper et al., 2004</xref>), but so far there are no reports of temperature in preclinical or early AD.</p>
              <p id="P8">Here, in cognitively normal older adults, we tested whether lower Tb is associated with increased aggregated (tau radiotracer uptake) and soluble (plasma and CSF) tau pathology. Neurofibrillary tangle burden in Braak I–III stage brain regions was visualized with PET-MR imaging using the tau radiotracer [<sup>18</sup>F]MK-6240 (MK6240) (<xref rid="R75" ref-type="bibr">Pascoal et al., 2020</xref>; <xref rid="R9" ref-type="bibr">Betthauser et al., 2020</xref>; <xref rid="R118" ref-type="bibr">Yap et al., 2021</xref>), which has sub-nanomolar affinity for hyperphosphorylated tau in paired helical filament formation (<xref rid="R48" ref-type="bibr">Hostetler et al., 2016</xref>; <xref rid="R74" ref-type="bibr">Pascoal et al., 2018</xref>). Soluble markers of tau burden and tau phosphorylation included cerebrospinal fluid (CSF) and plasma tau phosphorylated at threonine 181 (P-tau). Like CSF P-tau, plasma P-tau is elevated prior to tau PET positivity and predicts future neurodegeneration and dementia onset (<xref rid="R50" ref-type="bibr">Janelidze et al., 2020</xref>; <xref rid="R53" ref-type="bibr">Karikari et al., 2020</xref>). Tb was continuously measured with ingestible telemetry (<xref rid="R49" ref-type="bibr">Huang et al., 2021</xref>; <xref rid="R104" ref-type="bibr">Travers et al., 2016</xref>; <xref rid="R66" ref-type="bibr">Monnard et al., 2017</xref>) for up to 48 h. Given reports of sleep-wake variation in tau phosphorylation in wild-type mice (<xref rid="R35" ref-type="bibr">Guisle et al., 2020</xref>), sleep-wake state was assessed with nocturnal polysomnography (NPSG) on both nights of this 48 h period to delineate whether tau pathology was differentially associated with Tb measured during sleep vs waking intervals.</p>
            </sec>
            <sec id="S6">
              <label>2.</label>
              <title>Materials &amp; methods</title>
              <sec id="S7">
                <label>2.1.</label>
                <title>Participants and screening procedures</title>
                <p id="P9">Subjects were recruited from the NYU Cohort, comprised of community dwelling cognitively normal volunteers derived from NIH/National Institute on Aging and Alzheimer’s Association supported studies. Data were collected from an ongoing cross-sectional observational study (R21AG055002) designed to assess the association between sleep parameters and tau pathology in cognitively normal older adults. All participants underwent medical, psychiatric, neurological and neuropsychological assessments; genetic testing for <italic toggle="yes">APOEε4</italic> status, and assessment for daytime somnolence with the Epworth Sleepiness Scale (ESS) (<xref rid="R51" ref-type="bibr">Johns, 1991</xref>).</p>
                <p id="P10">Medical screening included medical history, examination and routine blood tests, electrocardiogram, height and weight, and MRI. Exclusion criteria included a history of brain tumor; MRI evidence of brain damage or other serious neurological disorder; significant history of alcoholism or drug abuse or current alcoholism or drug abuse; a history of major psychiatric illness; Geriatric Depression Scale (short form) &gt;5; obesity (Body mass index &gt;30); insulin dependent diabetes; family history of early onset dementia; evidence of clinically relevant cardiac, pulmonary, endocrine or hematological conditions including thyroid disorders; irregular sleep-wake rhythms (based on 7 day home actigraphy recordings prior to lab visits) or significant obstructive sleep apnea (AHI4% ≥ 15); and medications known to affect thermoregulation or sleep.</p>
                <p id="P11">Cognitive screening included the Mini—Mental Status Examination, Clinical Dementia Rating scale and other elements of the National Alzheimer’s Coordinating Center (NACC) Uniform Data Set Neuropsychological Test Battery. The diagnosis of cognitively normal was made by an experienced clinician according to standard criteria, and based on the diagnostic interview with the participant and his/her study partner, together with review of all available information including cognitive test scores and neuroimaging.</p>
              </sec>
              <sec id="S8">
                <label>2.2.</label>
                <title>Integrated body temperature and sleep-wake state measurement</title>
                <p id="P12">Core body (gastrointestinal tract) temperature was measured with CorTemp ingestible pill-shaped telemetric sensors (CorTemp H.Q., Palmetto, FL) monitored by a wearable data recorder. Body temperature was continuously measured for up to 48 h, sampling every 10 s with an accuracy of ± 0.2 °C. This 48 h period (the ‘Total’ Tb interval) included two nights of NPSG in the sleep lab (the ‘Sleep’ interval) and the two subsequent days (the ‘Waking’ interval), see <xref rid="F1" ref-type="fig">Fig. 1</xref>. During the Waking interval, participants chose their location and behaved, i.e., ate, exercised and showered according to their usual schedule. Participants were asked to wear the Tb monitor, avoid naps, stay out of range of electronic devices, and complete a temperature log of events that might affect Tb recording. See <xref rid="SD1" ref-type="supplementary-material">Supplementary File 1</xref> for further details.</p>
              </sec>
              <sec id="S9">
                <label>2.3.</label>
                <title>Body temperature data processing and features</title>
                <p id="P13">Data were excluded by a researcher blind to tau data from participants with less than 24 h of recording, or within 1 h of the participant changing over sensors or the receiver being out of range. Data were then processed with ‘<bold>DRAGO</bold>’ (nonlinear smoothing of <bold>D</bold>ata with <bold>RA</bold>ndom <bold>G</bold>aps and <bold>O</bold>utliers), developed by co-author Dr. Ankit Parekh for identifying outliers and gaps caused by signal interference and loss (<xref rid="R72" ref-type="bibr">Parekh, 2021</xref>). DRAGO processed data were edited by a blind rater to correct obvious errors in fit where present. Circadian parameters were calculated to establish whether DRAGO processed data yielded plausible circadian parameters, see <xref rid="SD1" ref-type="supplementary-material">Supplementary File 1</xref> for further details of this analysis and DRAGO.</p>
                <p id="P14">Six features were calculated from DRAGO processed Tb data: 1–3) Mean Tb for Total, Sleep, and Waking intervals, and 4–6) The proportion (%) of temperature data points below a specified temperature threshold (37 °C) for each of these intervals, termed time of subthreshold temperature, or TimeSubThr. We chose a threshold of 37 °C given temperatures below this value were shown to cause hyperphosphorylation in rodent and human tau assays (<xref rid="R77" ref-type="bibr">Planel et al., 2004</xref>; <xref rid="R79" ref-type="bibr">Planel et al., 2008</xref>). The final threshold used for data analyses was that both closest to 37.0 °C and to the mean Tb for that interval in the final sample. This threshold was 37.0 °C for the Total interval, 36.8 °C for the Sleep interval, and 37.1 °C for the Waking interval. To ensure against spurious findings, neighboring thresholds +/− 0.1 °C (and closest to 37.0 °C) were tested, with the idea that a 0.1 °C difference is below the accuracy of Tb measurement (0.2 °C), so should not substantially affect correlations. Results for a given Tb–tau pathology correlation were considered significant if at least one other neighboring threshold was significant at <italic toggle="yes">p</italic> &lt; 0.05.</p>
              </sec>
              <sec id="S10">
                <label>2.4.</label>
                <title>Tau tangle PET-MR imaging</title>
                <p id="P15">PET-MR scans occurred within 29 ± 18 days of Tb measurement. See <xref rid="SD1" ref-type="supplementary-material">Supplementary File 2</xref> for further details of PET-MR image processing. Briefly, standard uptake value ratio (SUVR) values from images acquired during the 90–110 min post-injection interval were computed for all FreeSurfer regions, normalizing to cerebellar grey matter. MR-based partial volume correction (PVC) was performed using Rousset’s geometric matrix transfer method (<xref rid="R86" ref-type="bibr">Rousset et al., 1998</xref>). Data were analyzed from composite regions corresponding to Braak pathological stages I–III, their constituent right and left hemisphere brain subregions (Braak I: entorhinal cortex; Braak II: hippocampus; Braak III: parahippocampal gyrus, amygdala, fusiform gyrus, lingual gyrus), and control brain regions not expected to contain NFTs including the pericalcarine cortex, corpus callosum, and caudate nucleus. Partial volume corrected data were used for the main analysis given the higher signal to noise ratio; results from uncorrected data are also presented. Data from left hemisphere brain regions are presented in the main manuscript, and from right hemisphere regions, in <xref rid="SM1" ref-type="sec">supplementary materials</xref>.</p>
              </sec>
              <sec id="S11">
                <label>2.5.</label>
                <title>Plasma and CSF P-tau assays</title>
                <p id="P16">Fluoroscopically-guided lumbar punctures followed by venous blood samples were performed in the morning to early afternoon the day following Tb assessment using previously described procedures (<xref rid="R96" ref-type="bibr">Spiegel et al., 2016</xref>; <xref rid="R111" ref-type="bibr">Vanderstichele et al., 2012</xref>). This time of sampling was chosen to follow the ADNI guidelines recommending morning sampling (<xref rid="R39" ref-type="bibr">Hansson et al., 2018</xref>), which is also the consensus for clinical practice and the literature (<xref rid="R111" ref-type="bibr">Vanderstichele et al., 2012</xref>). Concentrations of CSF and plasma tau phosphorylated at threonine 181 (P-tau) were measured using Simoa HD-X instruments (Quanterix, Billerica, MA, USA) at the NYU Alzheimer’s Disease Center Biomarker Core according to the manufacturer’s instructions. See <xref rid="SD1" ref-type="supplementary-material">Supplementary File 2</xref> for further details.</p>
              </sec>
              <sec id="S12">
                <label>2.6.</label>
                <title>Statistical analyses</title>
                <p id="P17">Data analyses were performed using Matlab version R2020b (Mathworks, Inc., Natick, MA). Data were examined for outlier status (values less than the first quartile minus 1.5 × the interquartile range, or values greater than the third quartile plus 1.5 × the interquartile range) and tested for deviation from a normal distribution using the Shapiro-Wilk test. Roughly half of the variables examined either had outliers or non-normal distributions, thus non-parametric (Spearman rank) correlations (robust against outliers) were used for all correlations. Correlations driven by a single outlier value were rejected if results were not significant with this value deleted. Correlations involving Total Tb data were corrected via partial correlation by the ratio of time spent asleep vs awake, given participants who spent more time asleep had lower Total mean Tb (<italic toggle="yes">r</italic> = −0.53, <italic toggle="yes">p</italic> &lt; 0.05) and higher Total TimeSubThr (<italic toggle="yes">r</italic> = 0.62, p &lt; 0.05). To account for potential confounds, which included <italic toggle="yes">APOε4</italic> carrier status, BMI, age, sex, ethnicity, education, ESS, and AHI3a (sleep apnea), these variables were first correlated with the dependent and independent variable in all correlations. Resulting correlations were weak–moderate (<italic toggle="yes">r</italic> &lt; 0.45) and non-significant (<italic toggle="yes">p</italic> &gt; 0.1), meaning that no partial correlations were required; however, we note that when Tb–tau pathology correlations were corrected for these potential confounds, correlations were not diminished in magnitude or significance.</p>
              </sec>
            </sec>
            <sec id="S13">
              <label>3.</label>
              <title>Results</title>
              <sec id="S14">
                <label>3.1.</label>
                <title>Participant characteristics</title>
                <p id="P18">The final participants (all those who completed PET-MR imaging) were <italic toggle="yes">n</italic> = 21 community dwelling cognitively normal volunteers (81% female) of mean age 65.4 ± 5.2 years, with 38% <italic toggle="yes">APOε4</italic> carriers, mean BMI = 25.4 ± 3.5, minimal daytime sleepiness and normal thyroid function at the time of screening, see <xref rid="T1" ref-type="table">Table 1</xref> for participant characteristics. Several participants had mild or moderate sleep apnea (median AHI3a 6.43). All participants except for one had a Clinical Dementia Rating (CDR) score of 0; the mean Mini-Mental State Examination (MMSE) was 29.04 ± 1.4. One participant with CDR of 0.5 had a MMSE of 26. The amyloid beta status of participants, i.e., whether they exceeded preclinical AD thresholds for CSF or PET amyloid beta load, was unknown.</p>
              </sec>
              <sec id="S15">
                <label>3.2.</label>
                <title>Relationship between tau PET, plasma P-tau and CSF P-tau markers</title>
                <p id="P19">MK6240 PET-MR images were collected in 21 participants, plasma P-tau levels in 19, and CSF P-tau levels in 20 participants, see <xref rid="T2" ref-type="table">Table 2</xref> and <xref rid="F2" ref-type="fig">Fig. 2</xref>. Three of 19 subjects were positive according to CSF P-tau cut-offs for ‘T’ status in preclinical AD (60 pg / mL) (<xref rid="R38" ref-type="bibr">Hansson et al., 2006</xref>). <xref rid="F2" ref-type="fig">Fig. 2</xref> shows fused PET and MR images for example T+ and T− subjects. Arti-factual meningeal uptake was present in participants both with and without MK6240 parenchymal uptake, as previously reported (<xref rid="R27" ref-type="bibr">Gogola et al., 2021</xref>). Neither Braak composite region MK6240 PET SUVR values, nor CSF, nor plasma P-tau levels were associated with age in the current sample (<italic toggle="yes">r</italic> &lt; 0.30, <italic toggle="yes">p</italic> &gt; 0.05 for all comparisons). There were strong associations (<italic toggle="yes">r</italic> = 0.45–0.8, <italic toggle="yes">p</italic> &lt; 0.05) between soluble P-tau measures, and between soluble measures and MK6240 SUVR uptake in most Braak I-III composite regions and constituent subregions (<xref rid="F2" ref-type="fig">Fig. 2</xref>, <xref rid="SD1" ref-type="supplementary-material">Table S1</xref> in <xref rid="SD1" ref-type="supplementary-material">Supplementary File 3</xref>).</p>
              </sec>
              <sec id="S16">
                <label>3.3.</label>
                <title>Reliability of telemetric Tb assessment including DRAGO data processing</title>
                <p id="P20">Acceptable Tb data were collected for 15/21 participants, all with at least 33 h data acquired (mean 46.27 ± 15.6 h). Of the remaining six, two had Tb data &lt;24 h, two did not return the receiver, and in two, highly irregular Tb traces indicated receiver malfunction. <xref rid="F3" ref-type="fig">Fig. 3</xref> shows raw and DRAGO processed Tb data for one participant. DRAGO accurately filled data gaps and excluded outlier values in almost all (14/15) participants. Manual editing was required for one participant. Both direct and cosine analyses of DRAGO outputs yielded circadian parameters consistent with previous studies of circadian rectal Tb (<xref rid="R101" ref-type="bibr">Touitou et al., 1986</xref>; <xref rid="R116" ref-type="bibr">Weinert, 2010</xref>; <xref rid="R54" ref-type="bibr">Kelly, 2006</xref>). (<xref rid="SD1" ref-type="supplementary-material">Table S2</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary File 3</xref>). Amplitude calculated from DRAGO outputs was ~1.5 × greater than that derived from cosine analysis, as in previous studies (<xref rid="R85" ref-type="bibr">Refinetti et al., 2007</xref>).</p>
                <p id="P21">Total Mean Tb (mean 37.03 ± 0.17 °C) agreed with previous studies of rectal Tb (<xref rid="R101" ref-type="bibr">Touitou et al., 1986</xref>; <xref rid="R54" ref-type="bibr">Kelly, 2006</xref>; <xref rid="R99" ref-type="bibr">Sund-Levander et al., 2002</xref>). Waking Mean Tb (37.31 ± 0.17 °C) was higher than Total Mean Tb, whereas Sleep Mean Tb was lower (36.64 ± 0.15 °C), <italic toggle="yes">p</italic> &lt; 0.05 both comparisons, see <xref rid="T2" ref-type="table">Table 2</xref>. Total TimeSubThr was on average 47.67 ± 10.5%, consistent with the average Total Mean Tb near 37 °C (and threshold of 37 °C). Waking TimeSubThr (18.2 ± 9.4%) was higher than both Total TimeSubThr and Sleep TimeSubThr (92.31 ± 10.20%) p &lt; 0.05 for both comparisons. TimeSubThr was inversely related to mean Tb for all intervals (<italic toggle="yes">r</italic> &lt; 0.5, <italic toggle="yes">p</italic> &lt; 0.01 for all comparisons). For all intervals, Tb was not significantly and only weakly correlated with age, ESS, BMI, or the average temperature for New York City in the month of Tb measurement (<italic toggle="yes">r</italic> &lt; 0.35, <italic toggle="yes">p</italic> &gt; 0.10 for all comparisons), except for the correlation between ESS and mean Total Tb, which was moderate but still non-significant (<italic toggle="yes">r</italic> = −0.40, <italic toggle="yes">p</italic> = 0.12).</p>
              </sec>
              <sec id="S17">
                <label>3.4.</label>
                <title>Association between lower Tb and greater soluble and aggregated tau pathology</title>
                <p id="P22">Associations between Tb and tau measures were examined separately for each interval, results are shown in <xref rid="F4" ref-type="fig">Figs. 4</xref> and <xref rid="F5" ref-type="fig">5</xref> and correlations are tabulated in <xref rid="SD1" ref-type="supplementary-material">Tables S3</xref>–<xref rid="SD1" ref-type="supplementary-material">S8</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Files 3</xref> and <xref rid="SD1" ref-type="supplementary-material">4</xref>. Greater Total TimeSubThr was strongly (<italic toggle="yes">r</italic> = 0.6–0.7) and significantly (<italic toggle="yes">p</italic> &lt; 0.05) associated with plasma and CSF P-tau or aggregated tau, this Tb feature was strongly (r = 0.6–0.7) and significantly (p &lt; 0.05) associated with SUVR uptake in the Braak II region and bilateral hippocampi, and in Braak III parahippocampal gyrus and amygdala subgregions. Total TimeSubThr was moderately (<italic toggle="yes">r</italic> = 0.5–0.59) associated with SUVR uptake in Braak I and III regions at a trend level (<italic toggle="yes">p</italic> &lt; 0.1), and weakly (<italic toggle="yes">r</italic> = 0.30–0.45) and non-significantly (<italic toggle="yes">p</italic> &gt; 0.1) associated with SUVR uptake in Braak III subregions lingual and fusiform gyrus. Lower Total Mean Tb was weakly (<italic toggle="yes">r</italic> &gt; −0.39) associated with plasma and CSF P-tau at a non-significant level (<italic toggle="yes">p</italic> &gt; 0.10), and moderately (r between −0.4 and − 0.5) associated with Braak I-III SUVR regional and subregional uptake at a trend (<italic toggle="yes">p</italic> &lt; 0.10) or non-significant (<italic toggle="yes">p</italic> &gt; 0.10) level. No Total Tb feature was associated with SUVR uptake in control brain regions at greater than a weak strength (all <italic toggle="yes">r</italic> &lt; 0.39), and all associations were non-significant (<italic toggle="yes">p</italic> &gt; 0.05). All SUVR uptake results were similar for right hemisphere equivalents and non-PVC data.</p>
                <p id="P23">Greater Waking TimeSubThr was moderately (r = 0.5–0.6) associated with plasma P-tau at a trend level (p &lt; 0.10), and moderately (<italic toggle="yes">r</italic> = 0.4–0.5) associated with CSF P-tau at a non-significant level (<italic toggle="yes">p</italic> &gt; 0.10). For aggregated tau, this feature was strongly (r = 0.6–0.7) and significantly (<italic toggle="yes">p</italic> &lt; 0.05) associated with SUVR uptake in Braak I and II regions and subregions and parahippocampal gyrus, moderately (<italic toggle="yes">r</italic> = 0.50) associated with SUVR uptake in the amygdala at a trend level (<italic toggle="yes">p</italic> &lt; 0.1), and weakly (r &lt; 0.3) and non-significantly (<italic toggle="yes">p</italic> &gt; 0.1) associated with SUVR uptake in Braak III fusiform and lingual gyrus. Lower Waking Mean Tb was moderately (<italic toggle="yes">r</italic> = −0.50) associated with plasma P-tau at a trend level (p &lt; 0.1), and moderately (<italic toggle="yes">r</italic> &lt; 0.4) associated with CSF P-tau at non-significant level (p &gt; 0.1). For aggregated tau, this feature was strongly (r between −0.6 and − 0.7) and significantly (p &lt; 0.05) associated with SUVR uptake in Braak I and II regions and subregions, Braak III parahippocampal gyrus, and amygdala (r = 0.5–0.6). Waking Mean Tb was moderately (<italic toggle="yes">r</italic> = −0.52) associated with Braak III SUVR uptake at a trend level (p &lt; 0.1), and weakly-moderately (<italic toggle="yes">r</italic> &gt; −0.4) associated with SUVR uptake in the fusiform and lingual gyrus at a non-significant (p &gt; 0.1) level. Similar results were obtained for right hemisphere equivalents and non-PVC data. No Waking Tb feature was associated with SUVR uptake in control brain regions at greater than a weak strength (all <italic toggle="yes">r</italic> &lt; 0.35), and all associations were non-significant (<italic toggle="yes">p</italic> &gt; 0.05).</p>
                <p id="P24">For the Sleep interval, Sleep Mean Tb was only weakly (<italic toggle="yes">r</italic> &gt; −0.3) and non-significantly (<italic toggle="yes">p</italic> &gt; 0.10) associated with CSF and plasma P-tau and with SUVR uptake in all brain regions tested. Sleep TimeSubThr associations with all tau measures were weak-moderate (0.2–0.55) at non-significant (<italic toggle="yes">p</italic> &gt; 0.1) or trend (<italic toggle="yes">p</italic> &lt; 0.1) levels. In summary, Tb features consistent with lower Tb were substantially, and in the majority of tests, significantly associated with increased soluble and aggregated tau pathology, with a lack of correlation in control brain regions. For the Total Tb interval, TimeSubThr was more strongly associated with both aggregated and soluble tau pathology compared to Mean Tb. For the Waking interval, both TimeSubThr and Mean Tb were strongly and significantly associated with aggregated tau pathology in most regions. By contrast, associations for the Sleep interval were relatively weak and mostly insignificant.</p>
              </sec>
            </sec>
            <sec id="S18">
              <label>4.</label>
              <title>Discussion</title>
              <p id="P25">Age-related thermoregulatory dysfunction could be an important pathophysiological pathway to Alzheimer’s disease. To our knowledge, ours is the first study to relate Tb to tau pathology in humans. Lower Tb and greater tau pathology may be causally related as detailed in <xref rid="F6" ref-type="fig">Fig. 6</xref>. In Arm 1 of this hypothesized bidirectional interaction, body and brain temperature directly influence the thermodynamic conditions governing tau phosphorylation and aggregation. In Arm 2, AD pathology and associated causes of thermoregulatory neuronal dysfunction cause body and brain temperature dysregulation. We discuss our results in context of both arms, following discussion of methods used to measure Tb and tau pathology.</p>
              <p id="P26">The assays we used to measure tau pathology are state of the art biomarkers for AD diagnosis and prognosis. MK6240 (<xref rid="R75" ref-type="bibr">Pascoal et al., 2020</xref>; <xref rid="R118" ref-type="bibr">Yap et al., 2021</xref>) detects NFTs with more than twice the dynamic range of flortaucipir (<xref rid="R27" ref-type="bibr">Gogola et al., 2021</xref>), a widely-used FDA-approved tau radiotracer. Further, the topological pattern of MK6240 uptake more closely matches that seen in histological Braak staging, with a higher frequency of uptake in Braak I–III stages in amyloid beta negative cognitively normal and MCI older adults compared with flortacipir (<xref rid="R75" ref-type="bibr">Pascoal et al., 2020</xref>; <xref rid="R9" ref-type="bibr">Betthauser et al., 2020</xref>). While the current participant sample was limited by unknown amyloid beta status, NFT signal detection was supported by strong associations between MK6240 SUVR uptake and CSF P-tau and plasma P-tau, as previously reported for MK6240 SUVR global uptake in large samples of cognitively normal, MCI, and amyloid beta positive older adults (<xref rid="R53" ref-type="bibr">Karikari et al., 2020</xref>; <xref rid="R62" ref-type="bibr">Lee et al., 2020</xref>). Increased plasma P-tau 181 has been shown to predict detection of aggregated tau, neurodegeneration, and dementia onset with an advance of more than a decade (<xref rid="R50" ref-type="bibr">Janelidze et al., 2020</xref>; <xref rid="R8" ref-type="bibr">Barthelemy et al., 2020</xref>).</p>
              <p id="P27">Ingestible telemetry is known to yield Tb values closely correlated with rectal and esophageal (core) Tb measures (<xref rid="R17" ref-type="bibr">Byrne and Lim, 2007</xref>; <xref rid="R26" ref-type="bibr">Gant et al., 2006</xref>; <xref rid="R18" ref-type="bibr">Casa et al., 2007</xref>), but has been used in few human Tb studies (<xref rid="R49" ref-type="bibr">Huang et al., 2021</xref>; <xref rid="R66" ref-type="bibr">Monnard et al., 2017</xref>), perhaps due to the need for manual removal of outliers and gap data artifacts (<xref rid="R66" ref-type="bibr">Monnard et al., 2017</xref>; <xref rid="R85" ref-type="bibr">Refinetti et al., 2007</xref>; <xref rid="R84" ref-type="bibr">Refinetti, 2010</xref>). Previous studies of circadian Tb variation employed oral, axillary, or skin measurement sites (unreliably related to core Tb) or rectal values (<xref rid="R117" ref-type="bibr">Weitzman et al., 1982</xref>; <xref rid="R54" ref-type="bibr">Kelly, 2006</xref>; <xref rid="R85" ref-type="bibr">Refinetti et al., 2007</xref>; <xref rid="R20" ref-type="bibr">Czeisler et al., 1980</xref>; <xref rid="R60" ref-type="bibr">Krauchi and Wirz-Justice, 1994</xref>; <xref rid="R55" ref-type="bibr">Kelly, 2007</xref>). We found that our automated telemetric Tb data processing methodology successfully dealt with these artifacts, giving a reliable measure of core Tb that closely agreed with previous studies of rectal Tb (<xref rid="R101" ref-type="bibr">Touitou et al., 1986</xref>; <xref rid="R54" ref-type="bibr">Kelly, 2006</xref>; <xref rid="R99" ref-type="bibr">Sund-Levander et al., 2002</xref>). We are not aware of previous studies that quantified mean Tb over the waking or sleep interval, however our values agree with point measurements during these intervals (<xref rid="R66" ref-type="bibr">Monnard et al., 2017</xref>). Our automated telemetric data processing method there-fore advances Tb telemetry by facilitating accurate quantification of core body temperature over extended periods of time.</p>
              <p id="P28">The goal of our study was to ascertain a sample of Tb in the context of real-life behavioral conditions typical for each participant, in order to represent preceding longer-term Tb patterns which may influence tau phosphorylation. The assumption that Tb sampled over 48 h represents longer-term Tb that is characteristic for an individual is supported by previous studies of rectal temperature (<xref rid="R5" ref-type="bibr">Aschoff, 1998</xref>), but requires further testing within this specific Tb measurement protocol. Toward a real-life Tb sample, we included in our data analysis Tb variations associated with the sleep-wake transition, physical activity, and other Tb-impacting behaviors usual for each participant. Our approach contrasts with studies using Tb as a marker of the endogenous circadian system, in which constant routines and data exclusion are used to minimize ‘masking’ effects of Tb-impacting behaviors (<xref rid="R60" ref-type="bibr">Krauchi and Wirz-Justice, 1994</xref>; <xref rid="R23" ref-type="bibr">Duffy and Dijk, 2002</xref>).</p>
              <p id="P29">In general, little is known about how temperature variation within the physiological range influences neuronal function at the molecular level (<xref rid="F6" ref-type="fig">Fig. 6</xref>, Arm 1). However, the relation between body temperature and brain tau phosphorylation is extensively documented in laboratory animals, including hibernating species. Temperature variation within the physiological range is strongly correlated with phosphorylation at Ser 202/Thr 205 used for Braak staging (<xref rid="R12" ref-type="bibr">Braak and Braak, 1997</xref>), and other sites including Thr 181 and Thr 231 that are hyperphosphorylated in AD (<xref rid="R77" ref-type="bibr">Planel et al., 2004</xref>; <xref rid="R78" ref-type="bibr">Planel et al., 2007</xref>; <xref rid="R14" ref-type="bibr">Bretteville et al., 2012</xref>; <xref rid="R3" ref-type="bibr">Arendt et al., 2003</xref>). In in vitro studies of human tau, temperature decrease from 37.4 °C to 36.3 °C robustly increases phosphorylation at these three sites (<xref rid="R35" ref-type="bibr">Guisle et al., 2020</xref>). Our study extends this body of evidence to in vivo measurements in humans. Molecular mechanisms other than phosphorylation may also contribute to the relation between temperature and tau pathology in AD. Circadian variation in Tb regulates alternative gene splicing via modulation of SR protein phosphorylation (<xref rid="R81" ref-type="bibr">Preussner et al., 2017</xref>), as well as neuronal expression of the tau chaperone hsp70 (<xref rid="R105" ref-type="bibr">Tsukamoto et al., 2019</xref>; <xref rid="R15" ref-type="bibr">Buhr et al., 2010</xref>), a process that prevents tau aggregation (<xref rid="R21" ref-type="bibr">Dickey et al., 2007</xref>; <xref rid="R57" ref-type="bibr">Kim et al., 2017</xref>). More generally, protein folding and ligand binding are known to be highly temperature-dependent (<xref rid="R24" ref-type="bibr">Fields et al., 2015</xref>; <xref rid="R45" ref-type="bibr">Hochachka and Somero, 1968</xref>; <xref rid="R94" ref-type="bibr">Somero et al., 2017</xref>; <xref rid="R92" ref-type="bibr">Somero, 1975</xref>; <xref rid="R93" ref-type="bibr">Somero and Low, 1976</xref>).</p>
              <p id="P30">Associations between Tb and tau pathology may also arise from the effects of AD pathology upon thermoregulatory neurons (<xref rid="F6" ref-type="fig">Fig. 6</xref>, Arm 2). Neuronal groups that exhibit NFTs in early AD include the dorsal raphe, suprachiasmatic nucleus, median preoptic area, and orexin-synthesizing neurons in the lateral hypothalamus (<xref rid="R13" ref-type="bibr">Braak et al., 2011</xref>; <xref rid="R87" ref-type="bibr">Rub et al., 2016</xref>; <xref rid="R107" ref-type="bibr">Uematsu et al., 2018</xref>; <xref rid="R33" ref-type="bibr">Grinberg et al., 2009</xref>; <xref rid="R6" ref-type="bibr">Attems et al., 2012</xref>; <xref rid="R98" ref-type="bibr">Stratmann et al., 2016</xref>; <xref rid="R68" ref-type="bibr">Oh et al., 2019</xref>; <xref rid="R119" ref-type="bibr">Zhu et al., 2019</xref>; <xref rid="R100" ref-type="bibr">Swaab et al., 1992</xref>). All these groups have key thermoregulatory functions (<xref rid="R67" ref-type="bibr">Morrison and Nakamura, 2019</xref>; <xref rid="R106" ref-type="bibr">Tupone et al., 2011</xref>). The balance in causal flow between Arm 1 and Arm 2 may shift toward Arm 2 with AD progression, given that NFT burden in these neurons markedly increases with the onset of amyloid plaque deposition in medial temporal areas (<xref rid="R13" ref-type="bibr">Braak et al., 2011</xref>; <xref rid="R87" ref-type="bibr">Rub et al., 2016</xref>; <xref rid="R6" ref-type="bibr">Attems et al., 2012</xref>). Consistent with this scenario, various thermoregulatory disturbances have been reported in late-stage AD patients (<xref rid="R65" ref-type="bibr">Mishima et al., 1997</xref>; <xref rid="R41" ref-type="bibr">Harper et al., 2005</xref>; <xref rid="R82" ref-type="bibr">Prinz et al., 1984</xref>; <xref rid="R113" ref-type="bibr">Volicer et al., 2012</xref>; <xref rid="R42" ref-type="bibr">Harper et al., 2008</xref>; <xref rid="R88" ref-type="bibr">Satlin et al., 1995</xref>; <xref rid="R101" ref-type="bibr">Touitou et al., 1986</xref>; <xref rid="R69" ref-type="bibr">Okawa et al., 1991</xref>; <xref rid="R40" ref-type="bibr">Harper et al., 2004</xref>).</p>
              <p id="P31">We found lower Waking Tb was associated with tau radiotracer uptake in Braak I–III regions, suggesting an association between lower Tb and pathological tau phosphorylation. By contrast, in laboratory animals, tau hyperphosphorylation in hippocampal and neocortical neurons observed during hypothermic states including hibernation (<xref rid="R3" ref-type="bibr">Arendt et al., 2003</xref>) and sleep (<xref rid="R35" ref-type="bibr">Guisle et al., 2020</xref>) was reversible. Nonetheless, persistent hypothermia (with tau phosphorylation) in older adults could contribute to tau aggregation, and AD-associated molecular defects may impair reversibility (<xref rid="R80" ref-type="bibr">Planel et al., 2009</xref>). Further longitudinal studies are required to test this. Our finding that lower Tb was associated with tau pathology during waking but not during sleep is consistent with the idea that temperature decrease during sleep is more likely to induce physiological (reversible) tau phosphorylation. While the function of hypothermia induced tau phosphorylation is not known, Arendt et al. proposed that tau phosphorylation may have a functional role in linking brain temperature decrease during entry into hibernation to neuroprotective remodeling of cytoskeletal and synaptic neuronal elements (<xref rid="R4" ref-type="bibr">Arendt et al., 2015</xref>; <xref rid="R3" ref-type="bibr">Arendt et al., 2003</xref>; <xref rid="R1" ref-type="bibr">Arendt and Bullmann, 2013</xref>). If tau phosphorylation during sleep or torpor was selected for in ancestral mammals, it may be that functionally related processes co-evolved to mitigate against aggregation. For example, Tb decrease upon sleep onset facilitates subsequent slow wave sleep (<xref rid="R90" ref-type="bibr">Shapiro et al., 1989</xref>; <xref rid="R47" ref-type="bibr">Horne and Staff, 1983</xref>; <xref rid="R52" ref-type="bibr">Jordan et al., 1990</xref>; <xref rid="R16" ref-type="bibr">Bunnell et al., 1988</xref>), which may increase tau clearance (<xref rid="R25" ref-type="bibr">Fultz et al., 2019</xref>; <xref rid="R83" ref-type="bibr">Rasmussen et al., 2018</xref>; <xref rid="R43" ref-type="bibr">Harrison et al., 2020</xref>; <xref rid="R46" ref-type="bibr">Holth et al., 2019</xref>).</p>
              <p id="P32">A causal association between Tb dysregulation and tau pathology has therapeutic implications. Thermal interventions in older adults, for example hot baths or saunas, could prevent NFT formation. More frequent sauna bathing in middle-aged men is associated with halving of the risk of dementia in later years (<xref rid="R59" ref-type="bibr">Knekt et al., 2020</xref>), and in mice, sauna-like treatment robustly reduces tau phosphorylation via inducing mild hyperthermia (<xref rid="R36" ref-type="bibr">Guisle et al., 2022</xref>). Finally, targeting exercise toward raising Tb could help reverse some causes of hypothermia in older adults, including sedentary lifestyle and decreased muscle mass (<xref rid="R117" ref-type="bibr">Weitzman et al., 1982</xref>; <xref rid="R56" ref-type="bibr">Kenney and Munce, 2003</xref>; <xref rid="R11" ref-type="bibr">Blatteis, 2012</xref>; <xref rid="R28" ref-type="bibr">Gomolin et al., 2005</xref>; <xref rid="R116" ref-type="bibr">Weinert, 2010</xref>; <xref rid="R109" ref-type="bibr">Van Someren et al., 2002</xref>; <xref rid="R114" ref-type="bibr">Waalen and Buxbaum, 2011</xref>).</p>
              <p id="P33">Our study has several limitations. The participant sample was relatively small, limiting statistical power, and was predominantly female Caucasian. Larger samples with more balanced demographics are required. Data on some potential confounds including habitual physical activity, amyloid status, and total tau levels were not collected and should be collected in future studies. While plasma and CSF P-tau were measured the day after Tb measurement, the interval between Tb measurement and tau PET scanning was variable. Although we did examine the effect of sleep vs waking state upon Tb–tau pathology associations, we did not determine whether these associations were confounded or mediated by sleep duration or other markers of sleep efficiency. Given evidence that the sleep-wake cycle affects tau levels in mice and human (<xref rid="R46" ref-type="bibr">Holth et al., 2019</xref>), this should be examined in future studies with larger sample size.</p>
            </sec>
            <sec id="S19">
              <label>5.</label>
              <title>Conclusions</title>
              <p id="P34">We report that lower Tb in cognitively normal older adults is associated with greater CSF and plasma P-tau levels, as well as greater tau MK6240 uptake in early Braak regions. This association was stronger in the waking state, suggesting an interaction between sleep wake state, body temperature and tau pathology. Our novel automated Tb data processing algorithm generated consistent temperature values, advancing the technique of Tb telemetry. Future studies are necessary to confirm these results, to examine whether additional related Tb features relate to tau pathology, and to assess the contribution of age, amyloid beta deposition, sleep impairment and <italic toggle="yes">APOε4</italic> status. Other important future directions include longitudinal studies to elucidate causality, and characterize the temporal dynamics between Tb variation and phosphorylation in soluble P-tau markers.</p>
            </sec>
            <sec sec-type="supplementary-material" id="SM1">
              <title>Supplementary Material</title>
              <supplementary-material id="SD1" position="float" content-type="local-data">
                <label>Supplementary Material (zipped)</label>
                <media xlink:href="NIHMS1856912-supplement-Supplementary_Material__zipped_.zip" id="d64e1154" position="anchor"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="S21">
              <title>Acknowledgements</title>
              <p id="P36">We thank Olivia Krivitsky and Zanetta Kovbasyuk for assistance with preparing figures and tables.</p>
              <sec id="S22">
                <title>Funding</title>
                <p id="P37">This work was supported by grants from the NIH, including R21 AG055002, RF1AG057570, R56 AG058913, R01 AG012101, R01 AG022374, and R01 AG013616.</p>
              </sec>
            </ack>
            <fn-group>
              <fn id="FN1">
                <p id="P38">Ethics approval and consent to participate</p>
                <p id="P39">Both the New York University Grossman School of Medicine and Icahn School of Medicine at Mount Sinai institutional review boards approved the inclusion of human participants for this study. All participants provided written informed consent.</p>
              </fn>
              <fn id="FN2">
                <p id="P40">Consent for publication</p>
                <p id="P41">Both the New York University Grossman School of Medicine and Icahn School of Medicine at Mount Sinai institutional review boards approve the publication of anonymized study results from this cohort.</p>
              </fn>
              <fn id="FN3">
                <p id="P42">Credit author statement</p>
                <p id="P43">Esther M. Blessing: NYU Grossman School of Medicine, designed and conceptualized study, analyzed the data, wrote the manuscript. Ankit Parekh: Icahn School of Medicine at Mount Sinai, designed and conceptualized study, acquired and analyzed the data, revised the manuscript. Rebecca A. Betensky: analyzed the data, revised the manuscript. James Babb: analyzed the data, revised the manuscript. Natalie Saba: analyzed the data, revised the manuscript. Ludovic Debure: Acquired and analyzed the data. Andrew W. Varga: Icahn School of Medicine at Mount Sinai, designed and conceptualized study, acquired and analyzed the data, revised the manuscript. Indu Ayappa: Icahn School of Medicine at Mount Sinai, designed and conceptualized study, revised the manuscript. David M. Rapoport: Icahn School of Medicine at Mount Sinai, designed and conceptualized study, revised the manuscript. Tracy A. Butler: Weill Cornell Medical College, acquired data, revised the manuscript. Mony J. de Leon: Weill Cornell Medical College, designed and conceptualized study, revised the manuscript. Thomas Wisniewski: NYU Grossman School of Medicine, designed and conceptualized study, revised the manuscript. Brian J. Lopresti: University of Pittsburgh, analyzed the data, revised the manuscript. Ricardo S. Osorio: NYU Grossman School of Medicine, designed and conceptualized study, acquired the data, analyzed the data, revised the manuscript. All authors read and approved the final manuscript.</p>
              </fn>
              <fn fn-type="COI-statement" id="FN4">
                <p id="P44">Declaration of Competing Interest</p>
                <p id="P45">The authors declare that they have no competing interests.</p>
              </fn>
              <fn id="FN5">
                <p id="P46">Appendix A. Supplementary data</p>
                <p id="P47">Supplementary data to this article can be found online at <ext-link xlink:href="10.1016/j.nbd.2022.105748" ext-link-type="doi">https://doi.org/10.1016/j.nbd.2022.105748</ext-link>.</p>
              </fn>
            </fn-group>
            <sec sec-type="data-availability" id="S20">
              <title>Availability of supporting data and code</title>
              <p id="P35">Anonymized data and custom code written in Matlab version R2020b (Mathworks, Inc., Natick, MA) for DRAGO body temperature data pre-processing will be shared upon reasonable request.</p>
            </sec>
            <glossary>
              <title>Abbreviations:</title>
              <def-list>
                <def-item>
                  <term>AD</term>
                  <def>
                    <p id="P48">Alzheimer’s Disease</p>
                  </def>
                </def-item>
                <def-item>
                  <term>AHI</term>
                  <def>
                    <p id="P49">Apnea-Hypopnea Index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>BMI</term>
                  <def>
                    <p id="P50">Body mass index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CDR</term>
                  <def>
                    <p id="P51">Clinical Dementia Rating</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CSF</term>
                  <def>
                    <p id="P52">Cerebrospinal fluid</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DRAGO</term>
                  <def>
                    <p id="P53">Data with Random Gaps and Outliers</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ESS</term>
                  <def>
                    <p id="P54">Epworth Sleepiness Scale</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LP</term>
                  <def>
                    <p id="P55">Lumbar puncture</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MCI</term>
                  <def>
                    <p id="P56">Mild cognitive impairment</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MMSE</term>
                  <def>
                    <p id="P57">Mini-Mental State Examination</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MR</term>
                  <def>
                    <p id="P58">Magnetic resonance</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NFT</term>
                  <def>
                    <p id="P59">Neurofibrillary tangle</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NPSG</term>
                  <def>
                    <p id="P60">Nocturnal polysomnography</p>
                  </def>
                </def-item>
                <def-item>
                  <term>OSA</term>
                  <def>
                    <p id="P61">Obstructive sleep apnea</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PET</term>
                  <def>
                    <p id="P62">Positron emission tomography</p>
                  </def>
                </def-item>
                <def-item>
                  <term>P-tau</term>
                  <def>
                    <p id="P63">Tau phosphorylated at threonine 181</p>
                  </def>
                </def-item>
                <def-item>
                  <term>Tb</term>
                  <def>
                    <p id="P64">Body temperature</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TimeSubThr</term>
                  <def>
                    <p id="P65">Percent of time body temperature is under threshold</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SUVR</term>
                  <def>
                    <p id="P66">Standardized uptake volume ratio</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <mixed-citation publication-type="journal"><name><surname>Arendt</surname><given-names>T</given-names></name>, <name><surname>Bullmann</surname><given-names>T</given-names></name>, <year>2013</year>. <article-title>Neuronal plasticity in hibernation and the proposed role of the microtubule-associated protein tau as a “master switch” regulating synaptic gain in neuronal networks</article-title>. <source>Am. J. Phys. Regul. Integr. Comp. Phys</source><volume>305</volume>, <fpage>R478</fpage>–<lpage>R489</lpage>.</mixed-citation>
              </ref>
              <ref id="R2">
                <mixed-citation publication-type="journal"><name><surname>Arendt</surname><given-names>T</given-names></name>, <name><surname>Holzer</surname><given-names>M</given-names></name>, <name><surname>Fruth</surname><given-names>R</given-names></name>, <name><surname>Bruckner</surname><given-names>MK</given-names></name>, <name><surname>Gartner</surname><given-names>U</given-names></name>, <year>1995</year>. <article-title>Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A</article-title>. <source>Neuroscience</source><volume>69</volume>, <fpage>691</fpage>–<lpage>698</lpage>.<pub-id pub-id-type="pmid">8596639</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <mixed-citation publication-type="journal"><name><surname>Arendt</surname><given-names>T</given-names></name>, <etal/>, <year>2003</year>. <article-title>Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals</article-title>. <source>J. Neurosci</source><volume>23</volume>, <fpage>6972</fpage>–<lpage>6981</lpage>.<pub-id pub-id-type="pmid">12904458</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <mixed-citation publication-type="journal"><name><surname>Arendt</surname><given-names>T</given-names></name>, <name><surname>Stieler</surname><given-names>J</given-names></name>, <name><surname>Holzer</surname><given-names>M</given-names></name>, <year>2015</year>. <article-title>Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer’s disease pathology</article-title>. <source>J. Neural Transm. (Vienna)</source><volume>122</volume>, <fpage>531</fpage>–<lpage>539</lpage>.<pub-id pub-id-type="pmid">25480630</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <mixed-citation publication-type="journal"><name><surname>Aschoff</surname><given-names>J</given-names></name>, <year>1998</year>. <article-title>Circadian parameters as individual characteristics</article-title>. <source>J. Biol. Rhythm</source><volume>13</volume>, <fpage>123</fpage>–<lpage>131</lpage>.</mixed-citation>
              </ref>
              <ref id="R6">
                <mixed-citation publication-type="journal"><name><surname>Attems</surname><given-names>J</given-names></name>, <name><surname>Thal</surname><given-names>DR</given-names></name>, <name><surname>Jellinger</surname><given-names>KA</given-names></name>, <year>2012</year>. <article-title>The relationship between subcortical tau pathology and Alzheimer’s disease</article-title>. <source>Biochem. Soc. Trans</source><volume>40</volume>, <fpage>711</fpage>–<lpage>715</lpage>.<pub-id pub-id-type="pmid">22817721</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <mixed-citation publication-type="journal"><name><surname>Augustinack</surname><given-names>JC</given-names></name>, <name><surname>Schneider</surname><given-names>A</given-names></name>, <name><surname>Mandelkow</surname><given-names>EM</given-names></name>, <name><surname>Hyman</surname><given-names>BT</given-names></name>, <year>2002</year>. <article-title>Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease</article-title>. <source>Acta Neuropathol</source><volume>103</volume>, <fpage>26</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">11837744</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <mixed-citation publication-type="journal"><name><surname>Barthelemy</surname><given-names>NR</given-names></name>, <etal/>, <year>2020</year>. <article-title>A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease</article-title>. <source>Nat. Med</source><volume>26</volume>, <fpage>398</fpage>–<lpage>407</lpage>.<pub-id pub-id-type="pmid">32161412</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <mixed-citation publication-type="journal"><name><surname>Betthauser</surname><given-names>TJ</given-names></name>, <etal/>, <year>2020</year>. <article-title>Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age</article-title>. <source>Brain</source><volume>143</volume>, <fpage>320</fpage>–<lpage>335</lpage>.<pub-id pub-id-type="pmid">31886494</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <mixed-citation publication-type="journal"><name><surname>Biundo</surname><given-names>F</given-names></name>, <name><surname>Del Prete</surname><given-names>D</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Arancio</surname><given-names>O</given-names></name>, <name><surname>D’Adamio</surname><given-names>L</given-names></name>, <year>2018</year>. <article-title>A role for tau in learning, memory and synaptic plasticity</article-title>. <source>Sci. Rep</source><volume>8</volume>, <fpage>3184</fpage>.<pub-id pub-id-type="pmid">29453339</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <mixed-citation publication-type="journal"><name><surname>Blatteis</surname><given-names>CM</given-names></name>, <year>2012</year>. <article-title>Age-dependent changes in temperature regulation - a mini review</article-title>. <source>Gerontology</source><volume>58</volume>, <fpage>289</fpage>–<lpage>295</lpage>.<pub-id pub-id-type="pmid">22085834</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <mixed-citation publication-type="journal"><name><surname>Braak</surname><given-names>H</given-names></name>, <name><surname>Braak</surname><given-names>E</given-names></name>, <year>1997</year>. <article-title>Frequency of stages of Alzheimer-related lesions in different age categories</article-title>. <source>Neurobiol. Aging</source><volume>18</volume>, <fpage>351</fpage>–<lpage>357</lpage>.<pub-id pub-id-type="pmid">9330961</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <mixed-citation publication-type="journal"><name><surname>Braak</surname><given-names>H</given-names></name>, <name><surname>Thal</surname><given-names>DR</given-names></name>, <name><surname>Ghebremedhin</surname><given-names>E</given-names></name>, <name><surname>Del Tredici</surname><given-names>K</given-names></name>, <year>2011</year>. <article-title>Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years</article-title>. <source>J. Neuropathol. Exp. Neurol</source><volume>70</volume>, <fpage>960</fpage>–<lpage>969</lpage>.<pub-id pub-id-type="pmid">22002422</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <mixed-citation publication-type="journal"><name><surname>Bretteville</surname><given-names>A</given-names></name>, <etal/>, <year>2012</year>. <article-title>Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors</article-title>. <source>Sci. Rep</source><volume>2</volume>, <fpage>480</fpage>.<pub-id pub-id-type="pmid">22761989</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <mixed-citation publication-type="journal"><name><surname>Buhr</surname><given-names>ED</given-names></name>, <name><surname>Yoo</surname><given-names>SH</given-names></name>, <name><surname>Takahashi</surname><given-names>JS</given-names></name>, <year>2010</year>. <article-title>Temperature as a universal resetting cue for mammalian circadian oscillators</article-title>. <source>Science</source><volume>330</volume>, <fpage>379</fpage>–<lpage>385</lpage>.<pub-id pub-id-type="pmid">20947768</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <mixed-citation publication-type="journal"><name><surname>Bunnell</surname><given-names>DE</given-names></name>, <name><surname>Agnew</surname><given-names>JA</given-names></name>, <name><surname>Horvath</surname><given-names>SM</given-names></name>, <name><surname>Jopson</surname><given-names>L</given-names></name>, <name><surname>Wills</surname><given-names>M</given-names></name>, <year>1988</year>. <article-title>Passive body heating and sleep: influence of proximity to sleep</article-title>. <source>Sleep</source><volume>11</volume>, <fpage>210</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">3381061</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <mixed-citation publication-type="journal"><name><surname>Byrne</surname><given-names>C</given-names></name>, <name><surname>Lim</surname><given-names>CL</given-names></name>, <year>2007</year>. <article-title>The ingestible telemetric body core temperature sensor: a review of validity and exercise applications</article-title>. <source>Br. J. Sports Med</source><volume>41</volume>, <fpage>126</fpage>–<lpage>133</lpage>.<pub-id pub-id-type="pmid">17178778</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <mixed-citation publication-type="journal"><name><surname>Casa</surname><given-names>DJ</given-names></name>, <etal/>, <year>2007</year>. <article-title>Validity of devices that assess body temperature during outdoor exercise in the heat</article-title>. <source>J. Athl. Train</source><volume>42</volume>, <fpage>333</fpage>–<lpage>342</lpage>.<pub-id pub-id-type="pmid">18059987</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <mixed-citation publication-type="journal"><name><surname>Clark</surname><given-names>C</given-names></name>, <etal/>, <year>2021</year>. <article-title>Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression</article-title>. <source>Alzheimers Res. Ther</source><volume>13</volume>, <fpage>65</fpage>.<pub-id pub-id-type="pmid">33766131</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <mixed-citation publication-type="journal"><name><surname>Czeisler</surname><given-names>CA</given-names></name>, <name><surname>Zimmerman</surname><given-names>JC</given-names></name>, <name><surname>Ronda</surname><given-names>JM</given-names></name>, <name><surname>Moore-Ede</surname><given-names>MC</given-names></name>, <name><surname>Weitzman</surname><given-names>ED</given-names></name>, <year>1980</year>. <article-title>Timing of REM sleep is coupled to the circadian rhythm of body temperature in man</article-title>. <source>Sleep</source><volume>2</volume>, <fpage>329</fpage>–<lpage>346</lpage>.<pub-id pub-id-type="pmid">7403736</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <mixed-citation publication-type="journal"><name><surname>Dickey</surname><given-names>CA</given-names></name>, <etal/>, <year>2007</year>. <article-title>The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins</article-title>. <source>J. Clin. Invest</source><volume>117</volume>, <fpage>648</fpage>–<lpage>658</lpage>.<pub-id pub-id-type="pmid">17304350</pub-id></mixed-citation>
              </ref>
              <ref id="R22">
                <mixed-citation publication-type="journal"><name><surname>Dixit</surname><given-names>R</given-names></name>, <name><surname>Ross</surname><given-names>JL</given-names></name>, <name><surname>Goldman</surname><given-names>YE</given-names></name>, <name><surname>Holzbaur</surname><given-names>EL</given-names></name>, <year>2008</year>. <article-title>Differential regulation of dynein and kinesin motor proteins by tau</article-title>. <source>Science</source><volume>319</volume>, <fpage>1086</fpage>–<lpage>1089</lpage>.<pub-id pub-id-type="pmid">18202255</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <mixed-citation publication-type="journal"><name><surname>Duffy</surname><given-names>JF</given-names></name>, <name><surname>Dijk</surname><given-names>DJ</given-names></name>, <year>2002</year>. <article-title>Getting through to circadian oscillators: why use constant routines?</article-title><source>J. Biol. Rhythm</source><volume>17</volume>, <fpage>4</fpage>–<lpage>13</lpage>.</mixed-citation>
              </ref>
              <ref id="R24">
                <mixed-citation publication-type="journal"><name><surname>Fields</surname><given-names>PA</given-names></name>, <name><surname>Dong</surname><given-names>Y</given-names></name>, <name><surname>Meng</surname><given-names>X</given-names></name>, <name><surname>Somero</surname><given-names>GN</given-names></name>, <year>2015</year>. <article-title>Adaptations of protein structure and function to temperature: there is more than one way to ‘skin a cat’</article-title>. <source>J. Exp. Biol</source><volume>218</volume>, <fpage>1801</fpage>–<lpage>1811</lpage>.<pub-id pub-id-type="pmid">26085658</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <mixed-citation publication-type="journal"><name><surname>Fultz</surname><given-names>NE</given-names></name>, <etal/>, <year>2019</year>. <article-title>Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep</article-title>. <source>Science</source><volume>366</volume>, <fpage>628</fpage>–<lpage>631</lpage>.<pub-id pub-id-type="pmid">31672896</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <mixed-citation publication-type="journal"><name><surname>Gant</surname><given-names>N</given-names></name>, <name><surname>Atkinson</surname><given-names>G</given-names></name>, <name><surname>Williams</surname><given-names>C</given-names></name>, <year>2006</year>. <article-title>The validity and reliability of intestinal temperature during intermittent running</article-title>. <source>Med. Sci. Sports Exerc</source><volume>38</volume>, <fpage>1926</fpage>–<lpage>1931</lpage>.<pub-id pub-id-type="pmid">17095925</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <mixed-citation publication-type="journal"><name><surname>Gogola</surname><given-names>A</given-names></name>, <etal/>, <year>2021</year>. <article-title>Direct comparison of the tau PET tracers [(18)F]flortaucipir and [(18)F]MK-6240 in human subjects</article-title>. <source>J. Nucl. Med</source><volume>63</volume>, <fpage>108</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">33863821</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <mixed-citation publication-type="journal"><name><surname>Gomolin</surname><given-names>IH</given-names></name>, <name><surname>Aung</surname><given-names>MM</given-names></name>, <name><surname>Wolf-Klein</surname><given-names>G</given-names></name>, <name><surname>Auerbach</surname><given-names>C</given-names></name>, <year>2005</year>. <article-title>Older is colder: temperature range and variation in older people</article-title>. <source>J. Am. Geriatr. Soc</source><volume>53</volume>, <fpage>2170</fpage>–<lpage>2172</lpage>.<pub-id pub-id-type="pmid">16398904</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <mixed-citation publication-type="journal"><name><surname>Gong</surname><given-names>CX</given-names></name>, <name><surname>Iqbal</surname><given-names>K</given-names></name>, <year>2008</year>. <article-title>Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease</article-title>. <source>Curr. Med. Chem</source><volume>15</volume>, <fpage>2321</fpage>–<lpage>2328</lpage>.<pub-id pub-id-type="pmid">18855662</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <mixed-citation publication-type="journal"><name><surname>Gong</surname><given-names>CX</given-names></name>, <name><surname>Liu</surname><given-names>F</given-names></name>, <name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name>, <name><surname>Iqbal</surname><given-names>K</given-names></name>, <year>2005</year>. <article-title>Post-translational modifications of tau protein in Alzheimer’s disease</article-title>. <source>J. Neural Transm. (Vienna)</source><volume>112</volume>, <fpage>813</fpage>–<lpage>838</lpage>.<pub-id pub-id-type="pmid">15517432</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <mixed-citation publication-type="journal"><name><surname>Gotz</surname><given-names>J</given-names></name>, <name><surname>Halliday</surname><given-names>G</given-names></name>, <name><surname>Nisbet</surname><given-names>RM</given-names></name>, <year>2019</year>. <article-title>Molecular pathogenesis of the Tauopathies</article-title>. <source>Annu. Rev. Pathol</source><volume>14</volume>, <fpage>239</fpage>–<lpage>261</lpage>.<pub-id pub-id-type="pmid">30355155</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <mixed-citation publication-type="journal"><name><surname>Gratuze</surname><given-names>M</given-names></name>, <name><surname>Julien</surname><given-names>J</given-names></name>, <name><surname>Petry</surname><given-names>FR</given-names></name>, <name><surname>Morin</surname><given-names>F</given-names></name>, <name><surname>Planel</surname><given-names>E</given-names></name>, <year>2017</year>. <article-title>Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer’s disease-like tau pathology</article-title>. <source>Sci. Rep</source><volume>7</volume>, <fpage>46359</fpage>.<pub-id pub-id-type="pmid">28402338</pub-id></mixed-citation>
              </ref>
              <ref id="R33">
                <mixed-citation publication-type="journal"><name><surname>Grinberg</surname><given-names>LT</given-names></name>, <etal/>, <year>2009</year>. <article-title>The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset?</article-title><source>Neuropathol. Appl. Neurobiol</source><volume>35</volume>, <fpage>406</fpage>–<lpage>416</lpage>.<pub-id pub-id-type="pmid">19508444</pub-id></mixed-citation>
              </ref>
              <ref id="R34">
                <mixed-citation publication-type="journal"><name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name>, <etal/>, <year>1986</year>. <article-title>Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source><volume>83</volume>, <fpage>4913</fpage>–<lpage>4917</lpage>.<pub-id pub-id-type="pmid">3088567</pub-id></mixed-citation>
              </ref>
              <ref id="R35">
                <mixed-citation publication-type="journal"><name><surname>Guisle</surname><given-names>I</given-names></name>, <etal/>, <year>2020</year>. <article-title>Circadian and sleep/wake-dependent variations in tau phosphorylation are driven by temperature</article-title>. <source>Sleep</source><volume>43</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
              </ref>
              <ref id="R36">
                <mixed-citation publication-type="journal"><name><surname>Guisle</surname><given-names>I</given-names></name>, <etal/>, <year>2022</year>. <article-title>Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia</article-title>. <source>Neurobiol. Aging</source><volume>113</volume>, <fpage>118</fpage>–<lpage>130</lpage>.<pub-id pub-id-type="pmid">35334439</pub-id></mixed-citation>
              </ref>
              <ref id="R37">
                <mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>T</given-names></name>, <name><surname>Noble</surname><given-names>W</given-names></name>, <name><surname>Hanger</surname><given-names>DP</given-names></name>, <year>2017</year>. <article-title>Roles of tau protein in health and disease</article-title>. <source>Acta Neuropathol</source><volume>133</volume>, <fpage>665</fpage>–<lpage>704</lpage>.<pub-id pub-id-type="pmid">28386764</pub-id></mixed-citation>
              </ref>
              <ref id="R38">
                <mixed-citation publication-type="journal"><name><surname>Hansson</surname><given-names>O</given-names></name>, <etal/>, <year>2006</year>. <article-title>Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study</article-title>. <source>Lancet Neurol</source><volume>5</volume>, <fpage>228</fpage>–<lpage>234</lpage>.<pub-id pub-id-type="pmid">16488378</pub-id></mixed-citation>
              </ref>
              <ref id="R39">
                <mixed-citation publication-type="journal"><name><surname>Hansson</surname><given-names>O</given-names></name>, <etal/>, <year>2018</year>. <article-title>CSF biomarkers of Alzheimer’s disease concord with amyloid-beta PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts</article-title>. <source>Alzheimers Dement</source><volume>14</volume>, <fpage>1470</fpage>–<lpage>1481</lpage>.<pub-id pub-id-type="pmid">29499171</pub-id></mixed-citation>
              </ref>
              <ref id="R40">
                <mixed-citation publication-type="journal"><name><surname>Harper</surname><given-names>DG</given-names></name>, <etal/>, <year>2004</year>. <article-title>Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease</article-title>. <source>Neurobiol. Aging</source><volume>25</volume>, <fpage>771</fpage>–<lpage>781</lpage>.<pub-id pub-id-type="pmid">15165702</pub-id></mixed-citation>
              </ref>
              <ref id="R41">
                <mixed-citation publication-type="journal"><name><surname>Harper</surname><given-names>DG</given-names></name>, <etal/>, <year>2005</year>. <article-title>Disturbance of endogenous circadian rhythm in aging and Alzheimer disease</article-title>. <source>Am. J. Geriatr. Psychiatry</source><volume>13</volume>, <fpage>359</fpage>–<lpage>368</lpage>.<pub-id pub-id-type="pmid">15879584</pub-id></mixed-citation>
              </ref>
              <ref id="R42">
                <mixed-citation publication-type="journal"><name><surname>Harper</surname><given-names>DG</given-names></name>, <etal/>, <year>2008</year>. <article-title>Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia</article-title>. <source>Brain</source><volume>131</volume>, <fpage>1609</fpage>–<lpage>1617</lpage>.<pub-id pub-id-type="pmid">18372313</pub-id></mixed-citation>
              </ref>
              <ref id="R43">
                <mixed-citation publication-type="journal"><name><surname>Harrison</surname><given-names>IF</given-names></name>, <etal/>, <year>2020</year>. <article-title>Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model</article-title>. <source>Brain</source><volume>143</volume>, <fpage>2576</fpage>–<lpage>2593</lpage>.<pub-id pub-id-type="pmid">32705145</pub-id></mixed-citation>
              </ref>
              <ref id="R44">
                <mixed-citation publication-type="journal"><name><surname>Hitrec</surname><given-names>T</given-names></name>, <etal/>, <year>2021</year>. <article-title>Reversible tau phosphorylation induced by synthetic torpor in the spinal cord of the rat</article-title>. <source>Front. Neuroanat</source><volume>15</volume>, <fpage>592288</fpage>.<pub-id pub-id-type="pmid">33603651</pub-id></mixed-citation>
              </ref>
              <ref id="R45">
                <mixed-citation publication-type="journal"><name><surname>Hochachka</surname><given-names>PW</given-names></name>, <name><surname>Somero</surname><given-names>GN</given-names></name>, <year>1968</year>. <article-title>The adaptation of enzymes to temperature</article-title>. <source>Comp. Biochem. Physiol</source><volume>27</volume>, <fpage>659</fpage>–<lpage>668</lpage>.<pub-id pub-id-type="pmid">5710275</pub-id></mixed-citation>
              </ref>
              <ref id="R46">
                <mixed-citation publication-type="journal"><name><surname>Holth</surname><given-names>JK</given-names></name>, <etal/>, <year>2019</year>. <article-title>The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans</article-title>. <source>Science</source><volume>363</volume>, <fpage>880</fpage>–<lpage>884</lpage>.<pub-id pub-id-type="pmid">30679382</pub-id></mixed-citation>
              </ref>
              <ref id="R47">
                <mixed-citation publication-type="journal"><name><surname>Horne</surname><given-names>JA</given-names></name>, <name><surname>Staff</surname><given-names>LH</given-names></name>, <year>1983</year>. <article-title>Exercise and sleep: body-heating effects</article-title>. <source>Sleep</source><volume>6</volume>, <fpage>36</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">6844796</pub-id></mixed-citation>
              </ref>
              <ref id="R48">
                <mixed-citation publication-type="journal"><name><surname>Hostetler</surname><given-names>ED</given-names></name>, <etal/>, <year>2016</year>. <article-title>Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles</article-title>. <source>J. Nucl. Med</source><volume>57</volume>, <fpage>1599</fpage>–<lpage>1606</lpage>.<pub-id pub-id-type="pmid">27230925</pub-id></mixed-citation>
              </ref>
              <ref id="R49">
                <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>Q</given-names></name>, <name><surname>Komarzynski</surname><given-names>S</given-names></name>, <name><surname>Bolborea</surname><given-names>M</given-names></name>, <name><surname>Finkenstadt</surname><given-names>B</given-names></name>, <name><surname>Levi</surname><given-names>FA</given-names></name>, <year>2021</year>. <article-title>Telemonitored human circadian temperature dynamics during daily routine</article-title>. <source>Front. Physiol</source><volume>12</volume>, <fpage>659973</fpage>.<pub-id pub-id-type="pmid">34040543</pub-id></mixed-citation>
              </ref>
              <ref id="R50">
                <mixed-citation publication-type="journal"><name><surname>Janelidze</surname><given-names>S</given-names></name>, <etal/>, <year>2020</year>. <article-title>Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia</article-title>. <source>Nat. Med</source><volume>26</volume>, <fpage>379</fpage>–<lpage>386</lpage>.<pub-id pub-id-type="pmid">32123385</pub-id></mixed-citation>
              </ref>
              <ref id="R51">
                <mixed-citation publication-type="journal"><name><surname>Johns</surname><given-names>MW</given-names></name>, <year>1991</year>. <article-title>A new method for measuring daytime sleepiness: the Epworth sleepiness scale</article-title>. <source>Sleep</source><volume>14</volume>, <fpage>540</fpage>–<lpage>545</lpage>.<pub-id pub-id-type="pmid">1798888</pub-id></mixed-citation>
              </ref>
              <ref id="R52">
                <mixed-citation publication-type="journal"><name><surname>Jordan</surname><given-names>J</given-names></name>, <name><surname>Montgomery</surname><given-names>I</given-names></name>, <name><surname>Trinder</surname><given-names>J</given-names></name>, <year>1990</year>. <article-title>The effect of afternoon body heating on body temperature and slow wave sleep</article-title>. <source>Psychophysiology</source><volume>27</volume>, <fpage>560</fpage>–<lpage>566</lpage>.<pub-id pub-id-type="pmid">2274619</pub-id></mixed-citation>
              </ref>
              <ref id="R53">
                <mixed-citation publication-type="journal"><name><surname>Karikari</surname><given-names>TK</given-names></name>, <etal/>, <year>2020</year>. <article-title>Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts</article-title>. <source>Lancet Neurol</source><volume>19</volume>, <fpage>422</fpage>–<lpage>433</lpage>.<pub-id pub-id-type="pmid">32333900</pub-id></mixed-citation>
              </ref>
              <ref id="R54">
                <mixed-citation publication-type="journal"><name><surname>Kelly</surname><given-names>G</given-names></name>, <year>2006</year>. <article-title>Body temperature variability (part 1): a review of the history of body temperature and its variability due to site selection, biological rhythms, fitness, and aging</article-title>. <source>Altern. Med. Rev</source><volume>11</volume>, <fpage>278</fpage>–<lpage>293</lpage>.<pub-id pub-id-type="pmid">17176167</pub-id></mixed-citation>
              </ref>
              <ref id="R55">
                <mixed-citation publication-type="journal"><name><surname>Kelly</surname><given-names>GS</given-names></name>, <year>2007</year>. <article-title>Body temperature variability (part 2): masking influences of body temperature variability and a review of body temperature variability in disease</article-title>. <source>Altern. Med. Rev</source><volume>12</volume>, <fpage>49</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">17397267</pub-id></mixed-citation>
              </ref>
              <ref id="R56">
                <mixed-citation publication-type="journal"><name><surname>Kenney</surname><given-names>WL</given-names></name>, <name><surname>Munce</surname><given-names>TA</given-names></name>, <year>2003</year>. <article-title>Invited review: aging and human temperature regulation</article-title>. <source>J. Appl. Physiol</source><volume>1985</volume> (<issue>95</issue>), <fpage>2598</fpage>–<lpage>2603</lpage>.</mixed-citation>
              </ref>
              <ref id="R57">
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>E</given-names></name>, <name><surname>Sakata</surname><given-names>K</given-names></name>, <name><surname>Liao</surname><given-names>FF</given-names></name>, <year>2017</year>. <article-title>Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation</article-title>. <source>PLoS Genet</source><volume>13</volume>, <fpage>e1006849</fpage>.<pub-id pub-id-type="pmid">28678786</pub-id></mixed-citation>
              </ref>
              <ref id="R58">
                <mixed-citation publication-type="journal"><name><surname>Kimura</surname><given-names>T</given-names></name>, <etal/>, <year>2014</year>. <article-title>Microtubule-associated protein tau is essential for long-term depression in the hippocampus</article-title>. <source>Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci</source><volume>369</volume>, <fpage>20130144</fpage>.<pub-id pub-id-type="pmid">24298146</pub-id></mixed-citation>
              </ref>
              <ref id="R59">
                <mixed-citation publication-type="journal"><name><surname>Knekt</surname><given-names>P</given-names></name>, <name><surname>Jarvinen</surname><given-names>R</given-names></name>, <name><surname>Rissanen</surname><given-names>H</given-names></name>, <name><surname>Heliovaara</surname><given-names>M</given-names></name>, <name><surname>Aromaa</surname><given-names>A</given-names></name>, <year>2020</year>. <article-title>Does sauna bathing protect against dementia?</article-title><source>Prev. Med. Rep</source><volume>20</volume>, <fpage>101221</fpage>.<pub-id pub-id-type="pmid">33088678</pub-id></mixed-citation>
              </ref>
              <ref id="R60">
                <mixed-citation publication-type="journal"><name><surname>Krauchi</surname><given-names>K</given-names></name>, <name><surname>Wirz-Justice</surname><given-names>A</given-names></name>, <year>1994</year>. <article-title>Circadian rhythm of heat production, heart rate, and skin and core temperature under unmasking conditions in men</article-title>. <source>Am. J. Phys</source><volume>267</volume>, <fpage>R819</fpage>–<lpage>R829</lpage>.</mixed-citation>
              </ref>
              <ref id="R61">
                <mixed-citation publication-type="journal"><name><surname>Laing</surname><given-names>KK</given-names></name>, <etal/>, <year>2020</year>. <article-title>Cerebrovascular disease promotes tau pathology in Alzheimer’s disease</article-title>. <source>Brain Commun</source><volume>2</volume>, <comment>fcaa132.</comment></mixed-citation>
              </ref>
              <ref id="R62">
                <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>J</given-names></name>, <etal/>, <year>2020</year>. <article-title>Cerebrospinal fluid biomarkers for the diagnosis and classification of Alzheimer’s disease Spectrum</article-title>. <source>J. Korean Med. Sci</source><volume>35</volume>, <fpage>e361</fpage>.<pub-id pub-id-type="pmid">33200589</pub-id></mixed-citation>
              </ref>
              <ref id="R63">
                <mixed-citation publication-type="journal"><name><surname>Lindwall</surname><given-names>G</given-names></name>, <name><surname>Cole</surname><given-names>RD</given-names></name>, <year>1984</year>. <article-title>Phosphorylation affects the ability of tau protein to promote microtubule assembly</article-title>. <source>J. Biol. Chem</source><volume>259</volume>, <fpage>5301</fpage>–<lpage>5305</lpage>.<pub-id pub-id-type="pmid">6425287</pub-id></mixed-citation>
              </ref>
              <ref id="R64">
                <mixed-citation publication-type="journal"><name><surname>Luppi</surname><given-names>M</given-names></name>, <etal/>, <year>2019</year>. <article-title>Phosphorylation and Dephosphorylation of tau protein during synthetic torpor</article-title>. <source>Front. Neuroanat</source><volume>13</volume>, <fpage>57</fpage>.<pub-id pub-id-type="pmid">31244617</pub-id></mixed-citation>
              </ref>
              <ref id="R65">
                <mixed-citation publication-type="journal"><name><surname>Mishima</surname><given-names>K</given-names></name>, <etal/>, <year>1997</year>. <article-title>Different manifestations of circadian rhythms in senile dementia of Alzheimer’s type and multi-infarct dementia</article-title>. <source>Neurobiol. Aging</source><volume>18</volume>, <fpage>105</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">8983038</pub-id></mixed-citation>
              </ref>
              <ref id="R66">
                <mixed-citation publication-type="journal"><name><surname>Monnard</surname><given-names>CR</given-names></name>, <etal/>, <year>2017</year>. <article-title>Issues in continuous 24-h Core body temperature monitoring in humans using an ingestible capsule telemetric sensor</article-title>. <source>Front Endocrinol (Lausanne)</source><volume>8</volume>, <fpage>130</fpage>.<pub-id pub-id-type="pmid">28659868</pub-id></mixed-citation>
              </ref>
              <ref id="R67">
                <mixed-citation publication-type="journal"><name><surname>Morrison</surname><given-names>SF</given-names></name>, <name><surname>Nakamura</surname><given-names>K</given-names></name>, <year>2019</year>. <article-title>Central mechanisms for thermoregulation</article-title>. <source>Annu. Rev. Physiol</source><volume>81</volume>, <comment>null.</comment></mixed-citation>
              </ref>
              <ref id="R68">
                <mixed-citation publication-type="journal"><name><surname>Oh</surname><given-names>J</given-names></name>, <etal/>, <year>2019</year>. <article-title>Profound degeneration of wake-promoting neurons in Alzheimer’s disease</article-title>. <source>Alzheimers Dement</source><volume>15</volume>, <fpage>1253</fpage>–<lpage>1263</lpage>.<pub-id pub-id-type="pmid">31416793</pub-id></mixed-citation>
              </ref>
              <ref id="R69">
                <mixed-citation publication-type="journal"><name><surname>Okawa</surname><given-names>M</given-names></name>, <etal/>, <year>1991</year>. <article-title>Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment</article-title>. <source>Sleep</source><volume>14</volume>, <fpage>478</fpage>–<lpage>485</lpage>.<pub-id pub-id-type="pmid">1798879</pub-id></mixed-citation>
              </ref>
              <ref id="R70">
                <mixed-citation publication-type="journal"><name><surname>Ossenkoppele</surname><given-names>R</given-names></name>, <etal/>, <year>2016</year>. <article-title>Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease</article-title>. <source>Brain</source><volume>139</volume>, <fpage>1551</fpage>–<lpage>1567</lpage>.<pub-id pub-id-type="pmid">26962052</pub-id></mixed-citation>
              </ref>
              <ref id="R71">
                <mixed-citation publication-type="journal"><name><surname>Ossenkoppele</surname><given-names>R</given-names></name>, <etal/>, <year>2021</year>. <article-title>Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging</article-title>. <source>JAMA Neurol</source><volume>78</volume>, <fpage>961</fpage>–<lpage>971</lpage>.<pub-id pub-id-type="pmid">34180956</pub-id></mixed-citation>
              </ref>
              <ref id="R72">
                <mixed-citation publication-type="book"><name><surname>Parekh</surname><given-names>A</given-names></name>, <year>2021</year>. In: <name><surname>Obeid</surname><given-names>I</given-names></name>, <name><surname>Selesnick</surname><given-names>I</given-names></name>, <name><surname>Picone</surname><given-names>J</given-names></name> (Eds.), <part-title>Nonlinear Smoothing of Core Body Temperature Data with Random Gaps and Outliers (DRAGO)</part-title>. In <source>Biomedical Signal Processing</source>
<publisher-name>Springer International Publishing</publisher-name>, pp. <fpage>63</fpage>–<lpage>84</lpage>.</mixed-citation>
              </ref>
              <ref id="R73">
                <mixed-citation publication-type="journal"><name><surname>Pascoal</surname><given-names>TA</given-names></name>, <etal/>, <year>2017</year>. <article-title>Amyloid-beta and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease</article-title>. <source>Mol. Psychiatry</source><volume>22</volume>, <fpage>306</fpage>–<lpage>311</lpage>.<pub-id pub-id-type="pmid">27021814</pub-id></mixed-citation>
              </ref>
              <ref id="R74">
                <mixed-citation publication-type="journal"><name><surname>Pascoal</surname><given-names>TA</given-names></name>, <etal/>, <year>2018</year>. <article-title>In vivo quantification of neurofibrillary tangles with [(18)F] MK-6240</article-title>. <source>Alzheimers Res. Ther</source><volume>10</volume>, <fpage>74</fpage>.<pub-id pub-id-type="pmid">30064520</pub-id></mixed-citation>
              </ref>
              <ref id="R75">
                <mixed-citation publication-type="journal"><name><surname>Pascoal</surname><given-names>TA</given-names></name>, <etal/>, <year>2020</year>. <article-title>18F-MK-6240 PET for early and late detection of neurofibrillary tangles</article-title>. <source>Brain</source><volume>143</volume>, <fpage>2818</fpage>–<lpage>2830</lpage>.<pub-id pub-id-type="pmid">32671408</pub-id></mixed-citation>
              </ref>
              <ref id="R76">
                <mixed-citation publication-type="journal"><name><surname>Planel</surname><given-names>E</given-names></name>, <name><surname>Yasutake</surname><given-names>K</given-names></name>, <name><surname>Fujita</surname><given-names>SC</given-names></name>, <name><surname>Ishiguro</surname><given-names>K</given-names></name>, <year>2001</year>. <article-title>Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse</article-title>. <source>J. Biol. Chem</source><volume>276</volume>, <fpage>34298</fpage>–<lpage>34306</lpage>.<pub-id pub-id-type="pmid">11441005</pub-id></mixed-citation>
              </ref>
              <ref id="R77">
                <mixed-citation publication-type="journal"><name><surname>Planel</surname><given-names>E</given-names></name>, <etal/>, <year>2004</year>. <article-title>Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer’s disease</article-title>. <source>J. Neurosci</source><volume>24</volume>, <fpage>2401</fpage>–<lpage>2411</lpage>.<pub-id pub-id-type="pmid">15014115</pub-id></mixed-citation>
              </ref>
              <ref id="R78">
                <mixed-citation publication-type="journal"><name><surname>Planel</surname><given-names>E</given-names></name>, <etal/>, <year>2007</year>. <article-title>Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia</article-title>. <source>J. Neurosci</source><volume>27</volume>, <fpage>3090</fpage>–<lpage>3097</lpage>.<pub-id pub-id-type="pmid">17376970</pub-id></mixed-citation>
              </ref>
              <ref id="R79">
                <mixed-citation publication-type="journal"><name><surname>Planel</surname><given-names>E</given-names></name>, <etal/>, <year>2008</year>. <article-title>Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo</article-title>. <source>J. Neurosci</source><volume>28</volume>, <fpage>12798</fpage>–<lpage>12807</lpage>.<pub-id pub-id-type="pmid">19036972</pub-id></mixed-citation>
              </ref>
              <ref id="R80">
                <mixed-citation publication-type="journal"><name><surname>Planel</surname><given-names>E</given-names></name>, <etal/>, <year>2009</year>. <article-title>Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia</article-title>. <source>FASEB J</source><volume>23</volume>, <fpage>2595</fpage>–<lpage>2604</lpage>.<pub-id pub-id-type="pmid">19279139</pub-id></mixed-citation>
              </ref>
              <ref id="R81">
                <mixed-citation publication-type="journal"><name><surname>Preussner</surname><given-names>M</given-names></name>, <etal/>, <year>2017</year>. <article-title>Body temperature cycles control rhythmic alternative splicing in mammals</article-title>. <source>Mol. Cell</source><volume>67</volume>, <fpage>433</fpage>–<lpage>446</lpage>
<fpage>e434</fpage>.<pub-id pub-id-type="pmid">28689656</pub-id></mixed-citation>
              </ref>
              <ref id="R82">
                <mixed-citation publication-type="journal"><name><surname>Prinz</surname><given-names>PN</given-names></name>, <etal/>, <year>1984</year>. <article-title>Circadian temperature variation in healthy aged and in Alzheimer’s disease</article-title>. <source>J. Gerontol</source><volume>39</volume>, <fpage>30</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">6690585</pub-id></mixed-citation>
              </ref>
              <ref id="R83">
                <mixed-citation publication-type="journal"><name><surname>Rasmussen</surname><given-names>MK</given-names></name>, <name><surname>Mestre</surname><given-names>H</given-names></name>, <name><surname>Nedergaard</surname><given-names>M</given-names></name>, <year>2018</year>. <article-title>The glymphatic pathway in neurological disorders</article-title>. <source>Lancet Neurol</source><volume>17</volume>, <fpage>1016</fpage>–<lpage>1024</lpage>.<pub-id pub-id-type="pmid">30353860</pub-id></mixed-citation>
              </ref>
              <ref id="R84">
                <mixed-citation publication-type="journal"><name><surname>Refinetti</surname><given-names>R</given-names></name>, <year>2010</year>. <article-title>The circadian rhythm of body temperature</article-title>. <source>Front Biosci. (Landmark Ed)</source><volume>15</volume>, <fpage>564</fpage>–<lpage>594</lpage>.<pub-id pub-id-type="pmid">20036834</pub-id></mixed-citation>
              </ref>
              <ref id="R85">
                <mixed-citation publication-type="journal"><name><surname>Refinetti</surname><given-names>R</given-names></name>, <name><surname>Lissen</surname><given-names>GC</given-names></name>, <name><surname>Halberg</surname><given-names>F</given-names></name>, <year>2007</year>. <article-title>Procedures for numerical analysis of circadian rhythms</article-title>. <source>Biol. Rhythm. Res</source><volume>38</volume>, <fpage>275</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">23710111</pub-id></mixed-citation>
              </ref>
              <ref id="R86">
                <mixed-citation publication-type="journal"><name><surname>Rousset</surname><given-names>OG</given-names></name>, <name><surname>Ma</surname><given-names>Y</given-names></name>, <name><surname>Evans</surname><given-names>AC</given-names></name>, <year>1998</year>. <article-title>Correction for partial volume effects in PET: principle and validation</article-title>. <source>J. Nucl. Med</source><volume>39</volume>, <fpage>904</fpage>–<lpage>911</lpage>.<pub-id pub-id-type="pmid">9591599</pub-id></mixed-citation>
              </ref>
              <ref id="R87">
                <mixed-citation publication-type="journal"><name><surname>Rub</surname><given-names>U</given-names></name>, <etal/>, <year>2016</year>. <article-title>The brainstem tau cytoskeletal pathology of Alzheimer’s disease: a brief historical overview and description of its anatomical distribution pattern, evolutional features, Pathogenetic and clinical relevance</article-title>. <source>Curr. Alzheimer Res</source><volume>13</volume>, <fpage>1178</fpage>–<lpage>1197</lpage>.<pub-id pub-id-type="pmid">27264543</pub-id></mixed-citation>
              </ref>
              <ref id="R88">
                <mixed-citation publication-type="journal"><name><surname>Satlin</surname><given-names>A</given-names></name>, <name><surname>Volicer</surname><given-names>L</given-names></name>, <name><surname>Stopa</surname><given-names>EG</given-names></name>, <name><surname>Harper</surname><given-names>D</given-names></name>, <year>1995</year>. <article-title>Circadian locomotor activity and core-body temperature rhythms in Alzheimer’s disease</article-title>. <source>Neurobiol. Aging</source><volume>16</volume>, <fpage>765</fpage>–<lpage>771</lpage>.<pub-id pub-id-type="pmid">8532109</pub-id></mixed-citation>
              </ref>
              <ref id="R89">
                <mixed-citation publication-type="journal"><name><surname>Scheltens</surname><given-names>P</given-names></name>, <etal/>, <year>2021</year>. <article-title>Alzheimer’s disease</article-title>. <source>Lancet</source><volume>397</volume>, <fpage>1577</fpage>–<lpage>1590</lpage>.<pub-id pub-id-type="pmid">33667416</pub-id></mixed-citation>
              </ref>
              <ref id="R90">
                <mixed-citation publication-type="journal"><name><surname>Shapiro</surname><given-names>CM</given-names></name>, <name><surname>Allan</surname><given-names>M</given-names></name>, <name><surname>Driver</surname><given-names>H</given-names></name>, <name><surname>Mitchell</surname><given-names>D</given-names></name>, <year>1989</year>. <article-title>Thermal load alters sleep</article-title>. <source>Biol. Psychiatry</source><volume>26</volume>, <fpage>736</fpage>–<lpage>740</lpage>.<pub-id pub-id-type="pmid">2804195</pub-id></mixed-citation>
              </ref>
              <ref id="R91">
                <mixed-citation publication-type="journal"><name><surname>Shukla</surname><given-names>V</given-names></name>, <name><surname>Skuntz</surname><given-names>S</given-names></name>, <name><surname>Pant</surname><given-names>HC</given-names></name>, <year>2012</year>. <article-title>Deregulated Cdk5 activity is involved in inducing Alzheimer’s disease</article-title>. <source>Arch. Med. Res</source><volume>43</volume>, <fpage>655</fpage>–<lpage>662</lpage>.<pub-id pub-id-type="pmid">23142263</pub-id></mixed-citation>
              </ref>
              <ref id="R92">
                <mixed-citation publication-type="journal"><name><surname>Somero</surname><given-names>GN</given-names></name>, <year>1975</year>. <article-title>Temperature as a selective factor in protein evolution: the adaptational strategy of “compromise”</article-title>. <source>J. Exp. Zool</source><volume>194</volume>, <fpage>175</fpage>–<lpage>188</lpage>.<pub-id pub-id-type="pmid">1104753</pub-id></mixed-citation>
              </ref>
              <ref id="R93">
                <mixed-citation publication-type="journal"><name><surname>Somero</surname><given-names>GN</given-names></name>, <name><surname>Low</surname><given-names>PS</given-names></name>, <year>1976</year>. <article-title>Temperature: a ‘shaping force’ in protein evolution</article-title>. <source>Biochem. Soc. Symp</source><fpage>33</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">788719</pub-id></mixed-citation>
              </ref>
              <ref id="R94">
                <mixed-citation publication-type="book"><name><surname>Somero</surname><given-names>GN</given-names></name>, <name><surname>Lockwood</surname><given-names>BL</given-names></name>, <name><surname>Tomanek</surname><given-names>L</given-names></name>, <year>2017</year>. <source>Biochemical Adaptation : Response to Environmental Challenges, from life’s Origins to the Anthropocene</source><publisher-name>Sinauer Associates, Inc. Publishers</publisher-name>, <publisher-loc>Sunderland, Massachusetts</publisher-loc>.</mixed-citation>
              </ref>
              <ref id="R95">
                <mixed-citation publication-type="journal"><name><surname>Sontag</surname><given-names>JM</given-names></name>, <name><surname>Sontag</surname><given-names>E</given-names></name>, <year>2014</year>. <article-title>Protein phosphatase 2A dysfunction in Alzheimer’s disease</article-title>. <source>Front. Mol. Neurosci</source><volume>7</volume>, <fpage>16</fpage>.<pub-id pub-id-type="pmid">24653673</pub-id></mixed-citation>
              </ref>
              <ref id="R96">
                <mixed-citation publication-type="journal"><name><surname>Spiegel</surname><given-names>J</given-names></name>, <etal/>, <year>2016</year>. <article-title>Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer’s disease</article-title>. <source>J. Alzheimer’s Dis. : JAD</source><volume>49</volume>, <fpage>93</fpage>–<lpage>100</lpage>.<pub-id pub-id-type="pmid">26444757</pub-id></mixed-citation>
              </ref>
              <ref id="R97">
                <mixed-citation publication-type="journal"><name><surname>Stieler</surname><given-names>JT</given-names></name>, <etal/>, <year>2011</year>. <article-title>The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation</article-title>. <source>PLoS One</source><volume>6</volume>, <fpage>e14530</fpage>.<pub-id pub-id-type="pmid">21267079</pub-id></mixed-citation>
              </ref>
              <ref id="R98">
                <mixed-citation publication-type="journal"><name><surname>Stratmann</surname><given-names>K</given-names></name>, <etal/>, <year>2016</year>. <article-title>Precortical phase of Alzheimer’s disease (AD)-related tau cytoskeletal pathology</article-title>. <source>Brain Pathol</source><volume>26</volume>, <fpage>371</fpage>–<lpage>386</lpage>.<pub-id pub-id-type="pmid">26193084</pub-id></mixed-citation>
              </ref>
              <ref id="R99">
                <mixed-citation publication-type="journal"><name><surname>Sund-Levander</surname><given-names>M</given-names></name>, <name><surname>Forsberg</surname><given-names>C</given-names></name>, <name><surname>Wahren</surname><given-names>LK</given-names></name>, <year>2002</year>. <article-title>Normal oral, rectal, tympanic and axillary body temperature in adult men and women: a systematic literature review</article-title>. <source>Scand. J. Caring Sci</source><volume>16</volume>, <fpage>122</fpage>–<lpage>128</lpage>.<pub-id pub-id-type="pmid">12000664</pub-id></mixed-citation>
              </ref>
              <ref id="R100">
                <mixed-citation publication-type="journal"><name><surname>Swaab</surname><given-names>DF</given-names></name>, <etal/>, <year>1992</year>. <article-title>Tau and ubiquitin in the human hypothalamus in aging and Alzheimer’s disease</article-title>. <source>Brain Res</source><volume>590</volume>, <fpage>239</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">1330213</pub-id></mixed-citation>
              </ref>
              <ref id="R101">
                <mixed-citation publication-type="journal"><name><surname>Touitou</surname><given-names>Y</given-names></name>, <etal/>, <year>1986</year>. <article-title>Age-related changes in both circadian and seasonal rhythms of rectal temperature with special reference to senile dementia of Alzheimer type</article-title>. <source>Gerontology</source><volume>32</volume>, <fpage>110</fpage>–<lpage>118</lpage>.<pub-id pub-id-type="pmid">3710170</pub-id></mixed-citation>
              </ref>
              <ref id="R102">
                <mixed-citation publication-type="journal"><name><surname>Tournissac</surname><given-names>M</given-names></name>, <name><surname>Vandal</surname><given-names>M</given-names></name>, <name><surname>Francois</surname><given-names>A</given-names></name>, <name><surname>Planel</surname><given-names>E</given-names></name>, <name><surname>Calon</surname><given-names>F</given-names></name>, <year>2017</year>. <article-title>Old age potentiates cold-induced tau phosphorylation: linking thermoregulatory deficit with Alzheimer’s disease</article-title>. <source>Neurobiol. Aging</source><volume>50</volume>, <fpage>25</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">27838492</pub-id></mixed-citation>
              </ref>
              <ref id="R103">
                <mixed-citation publication-type="journal"><name><surname>Tournissac</surname><given-names>M</given-names></name>, <etal/>, <year>2019</year>. <article-title>Repeated cold exposures protect a mouse model of Alzheimer’s disease against cold-induced tau phosphorylation</article-title>. <source>Mol. Metab</source><volume>22</volume>, <fpage>110</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">30770297</pub-id></mixed-citation>
              </ref>
              <ref id="R104">
                <mixed-citation publication-type="journal"><name><surname>Travers</surname><given-names>GJ</given-names></name>, <name><surname>Nichols</surname><given-names>DS</given-names></name>, <name><surname>Farooq</surname><given-names>A</given-names></name>, <name><surname>Racinais</surname><given-names>S</given-names></name>, <name><surname>Periard</surname><given-names>JD</given-names></name>, <year>2016</year>. <article-title>Validation of an ingestible temperature data logging and telemetry system during exercise in the heat</article-title>. <source>Temperature (Austin)</source><volume>3</volume>, <fpage>208</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">27857951</pub-id></mixed-citation>
              </ref>
              <ref id="R105">
                <mixed-citation publication-type="journal"><name><surname>Tsukamoto</surname><given-names>D</given-names></name>, <etal/>, <year>2019</year>. <article-title>Circadian transcription factor HSF1 regulates differential HSP70 gene transcription during the arousal-torpor cycle in mammalian hibernation</article-title>. <source>Sci. Rep</source><volume>9</volume>, <fpage>832</fpage>.<pub-id pub-id-type="pmid">30696859</pub-id></mixed-citation>
              </ref>
              <ref id="R106">
                <mixed-citation publication-type="journal"><name><surname>Tupone</surname><given-names>D</given-names></name>, <name><surname>Madden</surname><given-names>CJ</given-names></name>, <name><surname>Cano</surname><given-names>G</given-names></name>, <name><surname>Morrison</surname><given-names>SF</given-names></name>, <year>2011</year>. <article-title>An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis</article-title>. <source>J. Neurosci</source><volume>31</volume>, <fpage>15944</fpage>–<lpage>15955</lpage>.<pub-id pub-id-type="pmid">22049437</pub-id></mixed-citation>
              </ref>
              <ref id="R107">
                <mixed-citation publication-type="journal"><name><surname>Uematsu</surname><given-names>M</given-names></name>, <etal/>, <year>2018</year>. <article-title>Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid beta</article-title>. <source>Acta Neuropathol. Commun</source><volume>6</volume>, <fpage>1</fpage>.<pub-id pub-id-type="pmid">29298724</pub-id></mixed-citation>
              </ref>
              <ref id="R108">
                <mixed-citation publication-type="journal"><name><surname>van der Kant</surname><given-names>R</given-names></name>, <name><surname>Goldstein</surname><given-names>LSB</given-names></name>, <name><surname>Ossenkoppele</surname><given-names>R</given-names></name>, <year>2020</year>. <article-title>Amyloid-beta-independent regulators of tau pathology in Alzheimer disease</article-title>. <source>Nat. Rev. Neurosci</source><volume>21</volume>, <fpage>21</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">31780819</pub-id></mixed-citation>
              </ref>
              <ref id="R109">
                <mixed-citation publication-type="journal"><name><surname>Van Someren</surname><given-names>EJ</given-names></name>, <name><surname>Raymann</surname><given-names>RJ</given-names></name>, <name><surname>Scherder</surname><given-names>EJ</given-names></name>, <name><surname>Daanen</surname><given-names>HA</given-names></name>, <name><surname>Swaab</surname><given-names>DF</given-names></name>, <year>2002</year>. <article-title>Circadian and age-related modulation of thermoreception and temperature regulation: mechanisms and functional implications</article-title>. <source>Ageing Res. Rev</source><volume>1</volume>, <fpage>721</fpage>–<lpage>778</lpage>.<pub-id pub-id-type="pmid">12208240</pub-id></mixed-citation>
              </ref>
              <ref id="R110">
                <mixed-citation publication-type="journal"><name><surname>Vandal</surname><given-names>M</given-names></name>, <etal/>, <year>2016</year>. <article-title>Impaired thermoregulation and beneficial effects of thermoneutrality in the 3xTg-AD model of Alzheimer’s disease</article-title>. <source>Neurobiol. Aging</source><volume>43</volume>, <fpage>47</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">27255814</pub-id></mixed-citation>
              </ref>
              <ref id="R111">
                <mixed-citation publication-type="journal"><name><surname>Vanderstichele</surname><given-names>H</given-names></name>, <etal/>, <year>2012</year>. <article-title>Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer’s disease diagnosis: a consensus paper from the Alzheimer’s biomarkers standardization initiative</article-title>. <source>Alzheimers Dement</source><volume>8</volume>, <fpage>65</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">22047631</pub-id></mixed-citation>
              </ref>
              <ref id="R112">
                <mixed-citation publication-type="journal"><name><surname>Vershinin</surname><given-names>M</given-names></name>, <name><surname>Carter</surname><given-names>BC</given-names></name>, <name><surname>Razafsky</surname><given-names>DS</given-names></name>, <name><surname>King</surname><given-names>SJ</given-names></name>, <name><surname>Gross</surname><given-names>SP</given-names></name>, <year>2007</year>. <article-title>Multiple-motor based transport and its regulation by tau</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source><volume>104</volume>, <fpage>87</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">17190808</pub-id></mixed-citation>
              </ref>
              <ref id="R113">
                <mixed-citation publication-type="journal"><name><surname>Volicer</surname><given-names>L</given-names></name>, <name><surname>Harper</surname><given-names>DG</given-names></name>, <name><surname>Stopa</surname><given-names>EG</given-names></name>, <year>2012</year>. <article-title>Severe impairment of circadian rhythm in Alzheimer’s disease</article-title>. <source>J. Nutr. Health Aging</source><volume>16</volume>, <fpage>888</fpage>–<lpage>890</lpage>.<pub-id pub-id-type="pmid">23208027</pub-id></mixed-citation>
              </ref>
              <ref id="R114">
                <mixed-citation publication-type="journal"><name><surname>Waalen</surname><given-names>J</given-names></name>, <name><surname>Buxbaum</surname><given-names>JN</given-names></name>, <year>2011</year>. <article-title>Is older colder or colder older? The association of age with body temperature in 18,630 individuals</article-title>. <source>J. Gerontol. A Biol. Sci. Med. Sci</source><volume>66</volume>, <fpage>487</fpage>–<lpage>492</lpage>.<pub-id pub-id-type="pmid">21324956</pub-id></mixed-citation>
              </ref>
              <ref id="R115">
                <mixed-citation publication-type="journal"><name><surname>Wegmann</surname><given-names>S</given-names></name>, <name><surname>Biernat</surname><given-names>J</given-names></name>, <name><surname>Mandelkow</surname><given-names>E</given-names></name>, <year>2021</year>. <article-title>A current view on tau protein phosphorylation in Alzheimer’s disease</article-title>. <source>Curr. Opin. Neurobiol</source><volume>69</volume>, <fpage>131</fpage>–<lpage>138</lpage>.<pub-id pub-id-type="pmid">33892381</pub-id></mixed-citation>
              </ref>
              <ref id="R116">
                <mixed-citation publication-type="journal"><name><surname>Weinert</surname><given-names>D</given-names></name>, <year>2010</year>. <article-title>Circadian temperature variation and ageing</article-title>. <source>Ageing Res. Rev</source><volume>9</volume>, <fpage>51</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">19619672</pub-id></mixed-citation>
              </ref>
              <ref id="R117">
                <mixed-citation publication-type="journal"><name><surname>Weitzman</surname><given-names>ED</given-names></name>, <name><surname>Moline</surname><given-names>ML</given-names></name>, <name><surname>Czeisler</surname><given-names>CA</given-names></name>, <name><surname>Zimmerman</surname><given-names>JC</given-names></name>, <year>1982</year>. <article-title>Chronobiology of aging: temperature, sleep-wake rhythms and entrainment</article-title>. <source>Neurobiol. Aging</source><volume>3</volume>, <fpage>299</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">7170047</pub-id></mixed-citation>
              </ref>
              <ref id="R118">
                <mixed-citation publication-type="journal"><name><surname>Yap</surname><given-names>SY</given-names></name>, <etal/>, <year>2021</year>. <article-title>Discriminatory ability of next-generation tau PET tracers for Alzheimer’s disease</article-title>. <source>Brain</source><volume>144</volume>, <fpage>2284</fpage>–<lpage>2290</lpage>.<pub-id pub-id-type="pmid">33742656</pub-id></mixed-citation>
              </ref>
              <ref id="R119">
                <mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>K</given-names></name>, <etal/>, <year>2019</year>. <article-title>Primary age-related Tauopathy in human subcortical nuclei</article-title>. <source>Front. Neurosci</source><volume>13</volume>, <fpage>529</fpage>.<pub-id pub-id-type="pmid">31191227</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="F1">
              <label>Fig. 1. |</label>
              <caption>
                <p id="P67">Protocol for integrated measurement of body temperature and sleep. Time of body temperature sensor (pill) ingestion and recording indicated by line continuing from pill. Nocturnal polysomnography (NPSG) on Nights 1 and 2. Sleep interval (grey) included time between lights off (L. Off) and lights on (L. On), occurring in the sleep lab during NPSG. The Waking interval (white) included time on Days 1 and 2 between lights On and lights Off. During this time, subjects were free to return home and behave according to their normal schedule, indicated by activities bracketed under ‘?’.</p>
              </caption>
              <graphic xlink:href="nihms-1856912-f0001" position="float"/>
            </fig>
            <fig position="float" id="F2">
              <label>Fig. 2.</label>
              <caption>
                <p id="P68">Relationships between aggregated and soluble markers of tau pathology. A, Coronal [<sup>18</sup>F] MK-6240 tau tangle MR-PET images from two subjects: upper, T-negative 65 yo male, lower, T+ positive 63 yo female. B-D, associations between plasma P-tau, CSF P-tau and MK6240 SUVR uptake. Solid lines show linear regression, dashed lines show mean confidence intervals. Spearman’s rank correlation results at lower right of each plot.</p>
              </caption>
              <graphic xlink:href="nihms-1856912-f0002" position="float"/>
            </fig>
            <fig position="float" id="F3">
              <label>Fig. 3. |</label>
              <caption>
                <p id="P69">Raw and DRAGO processed body temperature data for one participant. Upper panel, raw body temperature (Tb) data, yellow shading indicates data outlier, blue shading indicates data gap. Lower panel, DRAGO processed Tb data divided into Sleep (nights 1 and 2) and Waking (days 1 and 2) intervals. Shaded areas show Tb values under indicated threshold (37 °C). Waking interval Tb metrics were Mean Tb, 37.15 °C, and time Tb under threshold (TimeSubThr), 21.44%.</p>
              </caption>
              <graphic xlink:href="nihms-1856912-f0003" position="float"/>
            </fig>
            <fig position="float" id="F4">
              <label>Fig. 4. |</label>
              <caption>
                <p id="P70">Correlation matrix of associations between body temperature, MK-6240 SUVR uptake in Braak I-III regions, CSF P-tau and plasma P-tau. Significant correlations are color coded by magnitude according to the indicated scale. Abbreviations: Tb, body temperature; SUVR, standardized uptake value ratio, TimeSubThr, body temperature under threshold.</p>
              </caption>
              <graphic xlink:href="nihms-1856912-f0004" position="float"/>
            </fig>
            <fig position="float" id="F5">
              <label>Fig. 5. |</label>
              <caption>
                <p id="P71">Associations between Waking Tb and MK-6240 SUVR uptake. A, C associations for mean Tb and MK6240 SUVR uptake in Braak I and parahippocampal gyrus regions, respectively. B, D, equivalent associations for the proportion of time Tb was under threshold during Waking intervals. Results of Spearman’s rank correlations are shown, dashed lines show mean confidence intervals. Abbreviations, PHG, parahippocampal gyrus, Tb, body temperature, TimeSubThr, time Tb was under threshold, MK6240, [<sup>18</sup>F]MK-6240 tau tangle tracer, SUVR, standardized uptake value ratio.</p>
              </caption>
              <graphic xlink:href="nihms-1856912-f0005" position="float"/>
            </fig>
            <fig position="float" id="F6">
              <label>Fig. 6. |</label>
              <caption>
                <p id="P72">Bidirectional relationship between body and brain temperature dysregulation and tau pathology. Arm 1 (black arrow) represents a direct effect of body and brain temperature upon tau phosphorylation and other molecular targets affecting tau pathology. Arm 2 (grey arrows) represents a multifactorial pathway by which tau pathology impacts body and brain temperature. Dashed line indicates minimal data available. Abbreviations, TR, thermoregulatory, S/WP, sleep- or wake promoting (neuron), CR, circadian rhythm.</p>
              </caption>
              <graphic xlink:href="nihms-1856912-f0006" position="float"/>
            </fig>
            <table-wrap position="float" id="T1">
              <label>Table 1</label>
              <caption>
                <p id="P73">Participant characteristics.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="middle" rowspan="1" colspan="1"/>
                    <th align="left" valign="middle" rowspan="1" colspan="1">n = 21</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Age</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">65.4 ± 5.2</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Female</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">17 (81%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BMI</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">24.05 ± 4.1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Education</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">17.3 ± 1.8</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CDR</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.02 ± 0.1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">GDS</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1.8 ± 0.5</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MMSE</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">29.04 ± 1.4</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ApoE4+</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">8 (38%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Sleep</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> AHI3a</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">8.14 ± 7.1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> ESS</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">4.4 ± 3.2</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Comorbidities</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Hypertension</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">3 (14%)</italic>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Cardiovascular Disease</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1 (5%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Diabetes</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1 (5%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Thyroid Disorders</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">4 (19%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Race</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">White</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">19 (90%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Black</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2 (10%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Medications</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Antidepressants</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">7 (33%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Statins</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">7 (33%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Antidiabetic</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1 (5%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Antihyperensive</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3 (14%)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> <italic toggle="yes">Thyroid</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">4 (19%)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1">
                  <p id="P74"><xref rid="T1" ref-type="table">Table 1</xref> | Results reported as mean ± SD or n (%). Abbreviations: BMI, body mass index, CDR, Clinical Dementia Rating, MMSE, Mini Mental State Examination, ESS, Epworth Sleepiness Scale, AHI3a, Apnea Hypopnea Index with 3% Desaturation, GDS, global dementia scale.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="T2" orientation="landscape">
              <label>Table 2</label>
              <caption>
                <p id="P75">Tau PET, plasma and CSF P-tau and body temperature group results</p>
              </caption>
              <table frame="hsides" rules="all">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <tbody>
                  <tr>
                    <th colspan="9" align="center" valign="middle" rowspan="1">MR PET Tau MK-6240 Tracer Uptake (SUVR) (<italic toggle="yes">n</italic> = 21)</th>
                  </tr>
                  <tr>
                    <th colspan="3" align="center" valign="middle" style="border-right-style: hidden" rowspan="1">Braak I–III</th>
                    <th align="center" valign="middle" style="border-right-style: hidden" rowspan="1" colspan="1">ERC</th>
                    <th align="center" valign="middle" style="border-right-style: hidden" rowspan="1" colspan="1">PHG</th>
                    <th align="center" valign="middle" style="border-right-style: hidden" rowspan="1" colspan="1">HPC</th>
                    <th align="center" valign="middle" style="border-right-style: hidden" rowspan="1" colspan="1">AMY</th>
                    <th align="center" valign="middle" style="border-right-style: hidden" rowspan="1" colspan="1">LNG</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">FUS</th>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.84 ± 0.81</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.79 ± 0.22</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.22 ± 0.34</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.74 ± 0.63</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.25 ± 0.35</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.77 ± 0.21</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.70 ± 0.34</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.23 ± 0.21</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.21 ± 0.41</td>
                  </tr>
                </tbody>
                <tbody>
                  <tr>
                    <th colspan="3" align="center" valign="middle" rowspan="1">Soluble P-tau Levels (pg / ml)</th>
                    <th colspan="3" align="center" valign="middle" rowspan="1">Mean Tb (°C)(n = 15)</th>
                    <th colspan="3" align="center" valign="middle" rowspan="1">TimeSubThr (%)(<italic toggle="yes">n</italic> = 15)</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" rowspan="1" colspan="1">Plasma (<italic toggle="yes">n</italic> = 19)</th>
                    <th colspan="2" align="center" valign="middle" rowspan="1">CSF (<italic toggle="yes">n</italic> = 20)</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">Total</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">Waking</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">Sleep</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">Total</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">Waking</th>
                    <th align="center" valign="middle" rowspan="1" colspan="1">Sleep</th>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.72 ± 0.78</td>
                    <td colspan="2" align="center" valign="middle" rowspan="1">50.20 ± 60.55</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">37.03 ± 0.17</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">37.31 ± 0.17</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">36.64 ± 0.15</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">47.67 ± 10.50</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">18.20 ± 9.44</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">92.31 ± 10.20</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN2">
                  <p id="P76"><xref rid="T2" ref-type="table">Table 2</xref> | Abbreviations: ERC, entorhinal cortex, PHG, parahippocampal gyrus, HPC, hippocampus, AMY, amygdala, LNG, lingual gyrus, FUS, fusiform gyrus, CSF, cerebrospinal fluid.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
